| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | extracellular matrix structural constituent conferring tensile strength | 1.07e-11 | 46 | 80 | 8 | GO:0030020 | |
| GeneOntologyMolecularFunction | extracellular matrix structural constituent | COL3A1 COL4A6 COL5A2 COL24A1 COL7A1 FBLN2 COL17A1 COL1A1 COL1A2 | 6.26e-08 | 188 | 80 | 9 | GO:0005201 |
| GeneOntologyMolecularFunction | platelet-derived growth factor binding | 1.33e-05 | 12 | 80 | 3 | GO:0048407 | |
| GeneOntologyMolecularFunction | DNA-binding transcription activator activity, RNA polymerase II-specific | JUNB KLF1 BARHL1 GLI2 PITX3 ELK1 NKX2-6 RAX TLX2 FOSL1 FOXC2 | 1.39e-05 | 560 | 80 | 11 | GO:0001228 |
| GeneOntologyMolecularFunction | DNA-binding transcription activator activity | JUNB KLF1 BARHL1 GLI2 PITX3 ELK1 NKX2-6 RAX TLX2 FOSL1 FOXC2 | 1.54e-05 | 566 | 80 | 11 | GO:0001216 |
| GeneOntologyMolecularFunction | low voltage-gated calcium channel activity | 4.74e-05 | 3 | 80 | 2 | GO:0008332 | |
| GeneOntologyMolecularFunction | voltage-gated sodium channel activity | 1.51e-04 | 26 | 80 | 3 | GO:0005248 | |
| GeneOntologyMolecularFunction | tRNA (uridine) methyltransferase activity | 1.57e-04 | 5 | 80 | 2 | GO:0016300 | |
| GeneOntologyMolecularFunction | RNA polymerase II transcription regulatory region sequence-specific DNA binding | JUNB KLF1 BARHL1 GLI2 MED8 PITX3 ELK1 ZBTB12 NKX2-6 FOXI3 RAX GSC2 CIC TLX2 FOSL1 FOXC2 | 1.88e-04 | 1459 | 80 | 16 | GO:0000977 |
| GeneOntologyMolecularFunction | RNA polymerase II cis-regulatory region sequence-specific DNA binding | JUNB KLF1 GLI2 MED8 PITX3 ELK1 ZBTB12 NKX2-6 FOXI3 RAX GSC2 TLX2 FOSL1 FOXC2 | 3.88e-04 | 1244 | 80 | 14 | GO:0000978 |
| GeneOntologyMolecularFunction | transcription coregulator activity | 4.08e-04 | 562 | 80 | 9 | GO:0003712 | |
| GeneOntologyMolecularFunction | DNA-binding transcription factor activity, RNA polymerase II-specific | JUNB KLF1 BARHL1 GLI2 PITX3 ELK1 ZBTB12 NKX2-6 FOXI3 RAX GSC2 CIC TLX2 FOSL1 FOXC2 | 4.32e-04 | 1412 | 80 | 15 | GO:0000981 |
| GeneOntologyMolecularFunction | cis-regulatory region sequence-specific DNA binding | JUNB KLF1 GLI2 MED8 PITX3 ELK1 ZBTB12 NKX2-6 FOXI3 RAX GSC2 TLX2 FOSL1 FOXC2 | 4.81e-04 | 1271 | 80 | 14 | GO:0000987 |
| GeneOntologyMolecularFunction | structural molecule activity | SHANK1 COL3A1 COL4A6 COL5A2 COL24A1 COL7A1 FBLN2 COL17A1 SNTB2 COL1A1 COL1A2 | 8.23e-04 | 891 | 80 | 11 | GO:0005198 |
| GeneOntologyMolecularFunction | sodium channel activity | 1.19e-03 | 52 | 80 | 3 | GO:0005272 | |
| GeneOntologyMolecularFunction | high voltage-gated calcium channel activity | 1.40e-03 | 14 | 80 | 2 | GO:0008331 | |
| GeneOntologyMolecularFunction | protein-macromolecule adaptor activity | SHANK1 NCOA6 ARID1B MED8 SYN1 SUPT20HL2 ELK1 MAML2 ZFPM1 ZXDB DMAP1 COL1A2 | 2.16e-03 | 1160 | 80 | 12 | GO:0030674 |
| GeneOntologyMolecularFunction | molecular adaptor activity | SHANK1 NCOA6 ARID1B MED8 SYN1 SUPT20HL2 ELK1 MAML2 ZFPM1 BAG6 ZXDB DMAP1 COL1A2 | 2.73e-03 | 1356 | 80 | 13 | GO:0060090 |
| GeneOntologyBiologicalProcess | embryo development | COL3A1 COL5A2 JUNB NCOA6 MEGF8 HCN4 KLF1 GLI2 HS6ST1 SUPT20HL2 NKX2-6 ZFPM1 FOXI3 BAG6 TLX2 FOSL1 COL1A1 FOXC2 | 5.14e-06 | 1437 | 78 | 18 | GO:0009790 |
| GeneOntologyBiologicalProcess | head development | COL3A1 NCOA6 GAK PYGO2 SZT2 BARHL1 GLI2 PITX3 NKX2-6 GRIN2D BAG6 RAX CIC COL1A1 | 7.88e-06 | 919 | 78 | 14 | GO:0060322 |
| GeneOntologyBiologicalProcess | collagen fibril organization | 1.02e-05 | 76 | 78 | 5 | GO:0030199 | |
| GeneOntologyBiologicalProcess | extracellular matrix organization | COL3A1 COL4A6 COL5A2 COL24A1 COL7A1 COL17A1 COL1A1 COL1A2 FOXC2 | 1.24e-05 | 377 | 78 | 9 | GO:0030198 |
| GeneOntologyBiologicalProcess | extracellular structure organization | COL3A1 COL4A6 COL5A2 COL24A1 COL7A1 COL17A1 COL1A1 COL1A2 FOXC2 | 1.27e-05 | 378 | 78 | 9 | GO:0043062 |
| GeneOntologyBiologicalProcess | external encapsulating structure organization | COL3A1 COL4A6 COL5A2 COL24A1 COL7A1 COL17A1 COL1A1 COL1A2 FOXC2 | 1.30e-05 | 379 | 78 | 9 | GO:0045229 |
| GeneOntologyBiologicalProcess | positive regulation of transcription by RNA polymerase II | JUNB NCOA6 KLF1 BARHL1 GLI2 MED8 PITX3 SUPT20HL2 TNKS ELK1 NKX2-6 MAML2 ZFPM1 RAX TLX2 FOSL1 FOXC2 | 1.36e-05 | 1390 | 78 | 17 | GO:0045944 |
| GeneOntologyBiologicalProcess | brain development | COL3A1 NCOA6 GAK PYGO2 SZT2 BARHL1 GLI2 PITX3 NKX2-6 GRIN2D BAG6 RAX CIC | 1.86e-05 | 859 | 78 | 13 | GO:0007420 |
| GeneOntologyBiologicalProcess | placenta blood vessel development | 2.29e-05 | 44 | 78 | 4 | GO:0060674 | |
| GeneOntologyBiologicalProcess | chordate embryonic development | COL3A1 JUNB NCOA6 MEGF8 HCN4 KLF1 GLI2 HS6ST1 NKX2-6 FOXI3 FOSL1 COL1A1 FOXC2 | 3.24e-05 | 906 | 78 | 13 | GO:0043009 |
| GeneOntologyBiologicalProcess | cellular response to amino acid stimulus | 3.33e-05 | 161 | 78 | 6 | GO:0071230 | |
| GeneOntologyBiologicalProcess | embryo development ending in birth or egg hatching | COL3A1 JUNB NCOA6 MEGF8 HCN4 KLF1 GLI2 HS6ST1 NKX2-6 FOXI3 FOSL1 COL1A1 FOXC2 | 4.20e-05 | 929 | 78 | 13 | GO:0009792 |
| GeneOntologyBiologicalProcess | cellular response to acid chemical | 5.65e-05 | 177 | 78 | 6 | GO:0071229 | |
| GeneOntologyBiologicalProcess | skin development | 8.26e-05 | 373 | 78 | 8 | GO:0043588 | |
| GeneOntologyBiologicalProcess | response to amino acid | 1.17e-04 | 202 | 78 | 6 | GO:0043200 | |
| GeneOntologyBiologicalProcess | membrane depolarization during SA node cell action potential | 1.40e-04 | 5 | 78 | 2 | GO:0086046 | |
| GeneOntologyBiologicalProcess | central nervous system development | COL3A1 NCOA6 ABCA2 GAK PYGO2 SZT2 BARHL1 GLI2 PITX3 NKX2-6 GRIN2D BAG6 RAX CIC | 1.42e-04 | 1197 | 78 | 14 | GO:0007417 |
| GeneOntologyBiologicalProcess | labyrinthine layer blood vessel development | 1.77e-04 | 29 | 78 | 3 | GO:0060716 | |
| GeneOntologyBiologicalProcess | negative regulation of sister chromatid cohesion | 2.10e-04 | 6 | 78 | 2 | GO:0045875 | |
| GeneOntologyBiologicalProcess | response to acid chemical | 2.26e-04 | 228 | 78 | 6 | GO:0001101 | |
| GeneOntologyBiologicalProcess | embryonic organ development | 2.63e-04 | 561 | 78 | 9 | GO:0048568 | |
| GeneOntologyBiologicalProcess | pharyngeal system development | 2.86e-04 | 34 | 78 | 3 | GO:0060037 | |
| GeneOntologyBiologicalProcess | direct ossification | 2.93e-04 | 7 | 78 | 2 | GO:0036072 | |
| GeneOntologyBiologicalProcess | intramembranous ossification | 2.93e-04 | 7 | 78 | 2 | GO:0001957 | |
| GeneOntologyBiologicalProcess | membrane depolarization during action potential | 3.40e-04 | 36 | 78 | 3 | GO:0086010 | |
| GeneOntologyBiologicalProcess | skeletal system development | 5.13e-04 | 615 | 78 | 9 | GO:0001501 | |
| GeneOntologyBiologicalProcess | lung development | 5.45e-04 | 269 | 78 | 6 | GO:0030324 | |
| GeneOntologyBiologicalProcess | respiratory tube development | 5.89e-04 | 273 | 78 | 6 | GO:0030323 | |
| GeneOntologyBiologicalProcess | SA node cell to atrial cardiac muscle cell signaling | 6.23e-04 | 10 | 78 | 2 | GO:0086018 | |
| GeneOntologyBiologicalProcess | SA node cell action potential | 6.23e-04 | 10 | 78 | 2 | GO:0086015 | |
| GeneOntologyCellularComponent | collagen trimer | COL3A1 COL4A6 COL5A2 COL24A1 COL7A1 COL17A1 MARCO COL1A1 COL1A2 | 4.42e-11 | 88 | 79 | 9 | GO:0005581 |
| GeneOntologyCellularComponent | complex of collagen trimers | 1.25e-10 | 21 | 79 | 6 | GO:0098644 | |
| GeneOntologyCellularComponent | fibrillar collagen trimer | 9.14e-08 | 12 | 79 | 4 | GO:0005583 | |
| GeneOntologyCellularComponent | banded collagen fibril | 9.14e-08 | 12 | 79 | 4 | GO:0098643 | |
| GeneOntologyCellularComponent | collagen type I trimer | 1.41e-05 | 2 | 79 | 2 | GO:0005584 | |
| GeneOntologyCellularComponent | collagen-containing extracellular matrix | COL3A1 COL4A6 COL5A2 COL24A1 COL7A1 FBLN2 COL17A1 MARCO COL1A1 COL1A2 | 3.03e-05 | 530 | 79 | 10 | GO:0062023 |
| GeneOntologyCellularComponent | chromatin | JUNB ARID1B KLF1 BARHL1 PITX3 SUPT20HL2 ELK1 NKX2-6 ZFPM1 ZNF385A RAX GSC2 CIC DMAP1 TLX2 FOSL1 FOXC2 | 3.06e-05 | 1480 | 79 | 17 | GO:0000785 |
| GeneOntologyCellularComponent | endoplasmic reticulum lumen | 3.64e-05 | 332 | 79 | 8 | GO:0005788 | |
| GeneOntologyCellularComponent | extracellular matrix | COL3A1 COL4A6 COL5A2 COL24A1 COL7A1 FBLN2 COL17A1 MARCO COL1A1 COL1A2 | 1.77e-04 | 656 | 79 | 10 | GO:0031012 |
| GeneOntologyCellularComponent | external encapsulating structure | COL3A1 COL4A6 COL5A2 COL24A1 COL7A1 FBLN2 COL17A1 MARCO COL1A1 COL1A2 | 1.82e-04 | 658 | 79 | 10 | GO:0030312 |
| GeneOntologyCellularComponent | voltage-gated sodium channel complex | 1.85e-03 | 17 | 79 | 2 | GO:0001518 | |
| HumanPheno | Atrophic scars | 9.24e-08 | 37 | 33 | 6 | HP:0001075 | |
| HumanPheno | Fragile skin | 9.24e-08 | 37 | 33 | 6 | HP:0001030 | |
| HumanPheno | Arterial rupture | 1.00e-07 | 8 | 33 | 4 | HP:0025019 | |
| HumanPheno | Cervical insufficiency | 9.87e-07 | 4 | 33 | 3 | HP:0030009 | |
| HumanPheno | Soft, doughy skin | 1.40e-06 | 14 | 33 | 4 | HP:0001027 | |
| HumanPheno | Dermal atrophy | 4.04e-06 | 107 | 33 | 7 | HP:0004334 | |
| HumanPheno | Atypical scarring of skin | 6.21e-06 | 74 | 33 | 6 | HP:0000987 | |
| HumanPheno | Molluscoid pseudotumors | 8.52e-06 | 7 | 33 | 3 | HP:0000993 | |
| HumanPheno | Uterine prolapse | 8.52e-06 | 7 | 33 | 3 | HP:0000139 | |
| HumanPheno | Genital hernia | 1.36e-05 | 8 | 33 | 3 | HP:0100823 | |
| HumanPheno | Cigarette-paper scars | 2.88e-05 | 10 | 33 | 3 | HP:0001073 | |
| HumanPheno | Scarring | 3.97e-05 | 102 | 33 | 6 | HP:0100699 | |
| HumanPheno | Biconcave flattened vertebrae | 4.07e-05 | 2 | 33 | 2 | HP:0003321 | |
| HumanPheno | Absent ossification of calvaria | 4.07e-05 | 2 | 33 | 2 | HP:0005623 | |
| HumanPheno | Severe generalized osteoporosis | 4.07e-05 | 2 | 33 | 2 | HP:0005897 | |
| HumanPheno | Femoral bowing present at birth, straightening with time | 4.07e-05 | 2 | 33 | 2 | HP:0005005 | |
| HumanPheno | Arterial dissection | 5.24e-05 | 12 | 33 | 3 | HP:0005294 | |
| HumanPheno | Arteriovenous fistula | 5.24e-05 | 12 | 33 | 3 | HP:0004947 | |
| HumanPheno | Abnormal uterine cervix morphology | 6.78e-05 | 13 | 33 | 3 | HP:0012888 | |
| HumanPheno | Bladder diverticulum | 7.43e-05 | 36 | 33 | 4 | HP:0000015 | |
| HumanPheno | Recurrent joint dislocation | 8.59e-05 | 14 | 33 | 3 | HP:0031869 | |
| HumanPheno | Hypermobility of distal interphalangeal joints | 1.22e-04 | 3 | 33 | 2 | HP:0006201 | |
| HumanPheno | Popcorn calcification | 1.22e-04 | 3 | 33 | 2 | HP:6000871 | |
| HumanPheno | Subcutaneous spheroids | 1.22e-04 | 3 | 33 | 2 | HP:0025014 | |
| HumanPheno | Premature rupture of membranes | 1.58e-04 | 17 | 33 | 3 | HP:0001788 | |
| HumanPheno | Soft skin | 1.65e-04 | 44 | 33 | 4 | HP:0000977 | |
| HumanPheno | Aplasia/Hypoplasia of the skin | 2.39e-04 | 201 | 33 | 7 | HP:0008065 | |
| HumanPheno | Piezogenic pedal papules | 2.42e-04 | 4 | 33 | 2 | HP:0025509 | |
| HumanPheno | Bowing of limbs due to multiple fractures | 2.42e-04 | 4 | 33 | 2 | HP:0003023 | |
| HumanPheno | Genital blistering | 2.42e-04 | 4 | 33 | 2 | HP:0031464 | |
| HumanPheno | Incisional hernia | 2.42e-04 | 4 | 33 | 2 | HP:0004872 | |
| HumanPheno | Thin skin | 2.47e-04 | 90 | 33 | 5 | HP:0000963 | |
| HumanPheno | Shoulder dislocation | 2.62e-04 | 20 | 33 | 3 | HP:0003834 | |
| HumanPheno | Dilatation of the cerebral artery | 2.94e-04 | 51 | 33 | 4 | HP:0004944 | |
| HumanPheno | Finger joint hypermobility | 3.18e-04 | 52 | 33 | 4 | HP:0006094 | |
| HumanPheno | Abnormal foramen magnum morphology | 4.02e-04 | 23 | 33 | 3 | HP:0002699 | |
| HumanPheno | Hypermobility of interphalangeal joints | 4.02e-04 | 5 | 33 | 2 | HP:0005620 | |
| HumanPheno | Basilar impression | 4.02e-04 | 5 | 33 | 2 | HP:0005758 | |
| HumanPheno | Abnormal cornea morphology | COL3A1 COL4A6 COL5A2 COL7A1 ARID1B PDE6A COL17A1 MEGF8 PITX3 RAX COL1A1 COL1A2 FOXC2 | 4.18e-04 | 744 | 33 | 13 | HP:0000481 |
| HumanPheno | Abnormality of hand joint mobility | 4.53e-04 | 57 | 33 | 4 | HP:0006256 | |
| HumanPheno | Blue sclerae | 5.77e-04 | 108 | 33 | 5 | HP:0000592 | |
| HumanPheno | Crumpled long bones | 6.01e-04 | 6 | 33 | 2 | HP:0006367 | |
| HumanPheno | Dermal translucency | 6.52e-04 | 27 | 33 | 3 | HP:0010648 | |
| HumanPheno | Abnormal elasticity of skin | 6.69e-04 | 238 | 33 | 7 | HP:0010647 | |
| HumanPheno | Abnormal heart valve physiology | 7.71e-04 | 403 | 33 | 9 | HP:0031653 | |
| HumanPheno | Pulp calcification | 8.38e-04 | 7 | 33 | 2 | HP:0003771 | |
| HumanPheno | Otosclerosis | 8.38e-04 | 7 | 33 | 2 | HP:0000362 | |
| HumanPheno | Phalangeal dislocation | 8.38e-04 | 7 | 33 | 2 | HP:0006243 | |
| HumanPheno | Small joint hypermobilty | 9.38e-04 | 69 | 33 | 4 | HP:0430046 | |
| HumanPheno | Aortic root aneurysm | 9.91e-04 | 70 | 33 | 4 | HP:0002616 | |
| HumanPheno | Mitral valve prolapse | 1.04e-03 | 123 | 33 | 5 | HP:0001634 | |
| HumanPheno | Blepharochalasis | 1.11e-03 | 8 | 33 | 2 | HP:0010749 | |
| MousePheno | small pterygoid bone | 4.15e-06 | 7 | 70 | 3 | MP:0004456 | |
| MousePheno | abnormal pterygoid bone morphology | 2.56e-05 | 12 | 70 | 3 | MP:0004453 | |
| MousePheno | pterygoid bone hypoplasia | 7.39e-05 | 3 | 70 | 2 | MP:0004455 | |
| MousePheno | abnormal palatine bone morphology | 8.03e-05 | 46 | 70 | 4 | MP:0005249 | |
| MousePheno | perinatal lethality | COL5A2 NCOA6 GAK ARID1B PYGO2 MAP6 GLI2 ZFPM1 FOXI3 MN1 BAG6 RAX MEX3C COL1A1 COL1A2 FOXC2 | 1.14e-04 | 1130 | 70 | 16 | MP:0002081 |
| MousePheno | abnormal pterygoid process morphology | 1.50e-04 | 21 | 70 | 3 | MP:0004452 | |
| MousePheno | abnormal temporal bone squamous part morphology | 1.50e-04 | 21 | 70 | 3 | MP:0004423 | |
| MousePheno | abnormal dermal layer morphology | 2.04e-04 | 108 | 70 | 5 | MP:0001243 | |
| MousePheno | abnormal spike wave discharge | 2.26e-04 | 24 | 70 | 3 | MP:0008840 | |
| MousePheno | abnormal compact bone lamellar structure | 2.45e-04 | 5 | 70 | 2 | MP:0010970 | |
| MousePheno | abnormal platelet alpha-granule number | 2.45e-04 | 5 | 70 | 2 | MP:0020429 | |
| MousePheno | decreased platelet alpha-granule number | 2.45e-04 | 5 | 70 | 2 | MP:0020431 | |
| MousePheno | decreased tendon stiffness | 2.45e-04 | 5 | 70 | 2 | MP:0003098 | |
| MousePheno | abnormal cutaneous collagen fibril morphology | 3.23e-04 | 27 | 70 | 3 | MP:0008438 | |
| MousePheno | abnormal palatine bone horizontal plate morphology | 3.60e-04 | 28 | 70 | 3 | MP:0004537 | |
| MousePheno | absent incus | 3.66e-04 | 6 | 70 | 2 | MP:0004318 | |
| MousePheno | abnormal tendon stiffness | 3.66e-04 | 6 | 70 | 2 | MP:0003097 | |
| MousePheno | abnormal tendon physiology | 3.66e-04 | 6 | 70 | 2 | MP:0030802 | |
| MousePheno | trachea stenosis | 3.66e-04 | 6 | 70 | 2 | MP:0010883 | |
| MousePheno | lethality during fetal growth through weaning, incomplete penetrance | COL3A1 COL5A2 NCOA6 COL17A1 KLF1 MAP6 GLI2 HS6ST1 ZFPM1 ZNF385A MN1 BAG6 CIC MEX3C COL1A1 | 3.70e-04 | 1124 | 70 | 15 | MP:0011112 |
| MousePheno | abnormal lung morphology | COL3A1 GAK PYGO2 MEGF8 HECTD3 GLI2 HS6ST1 BAG6 CIC MEX3C COL1A1 FOXC2 | 3.84e-04 | 767 | 70 | 12 | MP:0001175 |
| MousePheno | lethality during fetal growth through weaning, complete penetrance | NCOA6 COL7A1 GAK ARID1B PYGO2 MEGF8 KLF1 GLI2 HS6ST1 INPPL1 FOXI3 MN1 BAG6 COL1A1 COL1A2 FOXC2 | 4.30e-04 | 1269 | 70 | 16 | MP:0011111 |
| MousePheno | short vertebral body | 5.11e-04 | 7 | 70 | 2 | MP:0004706 | |
| MousePheno | abnormal skin tensile strength | 5.37e-04 | 32 | 70 | 3 | MP:0005275 | |
| MousePheno | abnormal tympanic ring morphology | 5.89e-04 | 33 | 70 | 3 | MP:0000030 | |
| MousePheno | abnormal presphenoid bone morphology | 5.89e-04 | 33 | 70 | 3 | MP:0004448 | |
| Domain | Collagen | COL3A1 COL4A6 COL5A2 COL24A1 COL7A1 COL17A1 MARCO COL1A1 COL1A2 | 1.08e-10 | 85 | 81 | 9 | IPR008160 |
| Domain | Collagen | COL3A1 COL4A6 COL5A2 COL24A1 COL7A1 COL17A1 MARCO COL1A1 COL1A2 | 1.08e-10 | 85 | 81 | 9 | PF01391 |
| Domain | Fib_collagen_C | 6.13e-10 | 11 | 81 | 5 | IPR000885 | |
| Domain | COLFI | 6.13e-10 | 11 | 81 | 5 | PF01410 | |
| Domain | NC1_FIB | 6.13e-10 | 11 | 81 | 5 | PS51461 | |
| Domain | Fib_collagen_C | 6.13e-10 | 11 | 81 | 5 | PD002078 | |
| Domain | COLFI | 6.13e-10 | 11 | 81 | 5 | SM00038 | |
| Domain | VDCC_T_a1 | 5.56e-05 | 3 | 81 | 2 | IPR005445 | |
| Domain | Homeobox_CS | 1.57e-04 | 186 | 81 | 6 | IPR017970 | |
| Domain | VWC | 2.38e-04 | 28 | 81 | 3 | PF00093 | |
| Domain | GAF | 3.85e-04 | 7 | 81 | 2 | PF01590 | |
| Domain | VWFC_1 | 5.06e-04 | 36 | 81 | 3 | PS01208 | |
| Domain | GAF | 5.11e-04 | 8 | 81 | 2 | IPR003018 | |
| Domain | GAF | 5.11e-04 | 8 | 81 | 2 | SM00065 | |
| Domain | Homeobox | 5.38e-04 | 234 | 81 | 6 | PF00046 | |
| Domain | HOMEOBOX_1 | 5.62e-04 | 236 | 81 | 6 | PS00027 | |
| Domain | HOX | 5.75e-04 | 237 | 81 | 6 | SM00389 | |
| Domain | VWC | 5.94e-04 | 38 | 81 | 3 | SM00214 | |
| Domain | VWFC_2 | 5.94e-04 | 38 | 81 | 3 | PS50184 | |
| Domain | HOMEOBOX_2 | 6.01e-04 | 239 | 81 | 6 | PS50071 | |
| Domain | Homeobox_dom | 6.01e-04 | 239 | 81 | 6 | IPR001356 | |
| Domain | GAF_dom-like | 6.56e-04 | 9 | 81 | 2 | IPR029016 | |
| Domain | - | 6.56e-04 | 9 | 81 | 2 | 3.30.450.40 | |
| Domain | VWF_dom | 7.99e-04 | 42 | 81 | 3 | IPR001007 | |
| Domain | VDCCAlpha1 | 8.17e-04 | 10 | 81 | 2 | IPR002077 | |
| Domain | - | 1.44e-03 | 283 | 81 | 6 | 1.10.10.60 | |
| Domain | OAR | 1.88e-03 | 15 | 81 | 2 | PF03826 | |
| Domain | OAR | 2.14e-03 | 16 | 81 | 2 | PS50803 | |
| Domain | OAR_dom | 2.14e-03 | 16 | 81 | 2 | IPR003654 | |
| Domain | PDEase | 3.03e-03 | 19 | 81 | 2 | IPR023088 | |
| Domain | Homeodomain-like | 3.20e-03 | 332 | 81 | 6 | IPR009057 | |
| Domain | PDEase_I | 3.70e-03 | 21 | 81 | 2 | PF00233 | |
| Domain | PDEASE_I | 3.70e-03 | 21 | 81 | 2 | PS00126 | |
| Domain | PDEase_CS | 3.70e-03 | 21 | 81 | 2 | IPR023174 | |
| Domain | - | 4.06e-03 | 22 | 81 | 2 | 1.10.1300.10 | |
| Domain | PDEase_catalytic_dom | 4.43e-03 | 23 | 81 | 2 | IPR002073 | |
| Domain | HDc | 4.82e-03 | 24 | 81 | 2 | SM00471 | |
| Domain | HD/PDEase_dom | 4.82e-03 | 24 | 81 | 2 | IPR003607 | |
| Domain | SAM | 6.62e-03 | 88 | 81 | 3 | SM00454 | |
| Domain | Homeobox_metazoa | 7.04e-03 | 90 | 81 | 3 | IPR020479 | |
| Domain | SAM_DOMAIN | 8.17e-03 | 95 | 81 | 3 | PS50105 | |
| Domain | SAM | 8.65e-03 | 97 | 81 | 3 | IPR001660 | |
| Pathway | REACTOME_COLLAGEN_CHAIN_TRIMERIZATION | 1.79e-11 | 44 | 64 | 8 | M27812 | |
| Pathway | REACTOME_ASSEMBLY_OF_COLLAGEN_FIBRILS_AND_OTHER_MULTIMERIC_STRUCTURES | 2.80e-10 | 61 | 64 | 8 | M27103 | |
| Pathway | REACTOME_COLLAGEN_CHAIN_TRIMERIZATION | 5.65e-10 | 41 | 64 | 7 | MM15538 | |
| Pathway | REACTOME_COLLAGEN_BIOSYNTHESIS_AND_MODIFYING_ENZYMES | 6.07e-10 | 67 | 64 | 8 | M26999 | |
| Pathway | PID_SYNDECAN_1_PATHWAY | 1.32e-09 | 46 | 64 | 7 | M198 | |
| Pathway | PID_AVB3_INTEGRIN_PATHWAY | 1.37e-09 | 74 | 64 | 8 | M160 | |
| Pathway | REACTOME_COLLAGEN_FORMATION | 6.65e-09 | 90 | 64 | 8 | M631 | |
| Pathway | REACTOME_COLLAGEN_BIOSYNTHESIS_AND_MODIFYING_ENZYMES | 1.02e-08 | 61 | 64 | 7 | MM14637 | |
| Pathway | REACTOME_COLLAGEN_DEGRADATION | 1.44e-08 | 64 | 64 | 7 | M26953 | |
| Pathway | REACTOME_COLLAGEN_FORMATION | 4.85e-08 | 76 | 64 | 7 | MM14573 | |
| Pathway | REACTOME_ASSEMBLY_OF_COLLAGEN_FIBRILS_AND_OTHER_MULTIMERIC_STRUCTURES | 9.37e-08 | 50 | 64 | 6 | MM14796 | |
| Pathway | REACTOME_COLLAGEN_DEGRADATION | 1.34e-07 | 53 | 64 | 6 | MM14566 | |
| Pathway | REACTOME_MET_ACTIVATES_PTK2_SIGNALING | 2.15e-07 | 30 | 64 | 5 | M27772 | |
| Pathway | REACTOME_NON_INTEGRIN_MEMBRANE_ECM_INTERACTIONS | 3.01e-07 | 32 | 64 | 5 | MM14924 | |
| Pathway | PID_INTEGRIN1_PATHWAY | 5.06e-07 | 66 | 64 | 6 | M18 | |
| Pathway | REACTOME_ANCHORING_FIBRIL_FORMATION | 5.08e-07 | 15 | 64 | 4 | M27161 | |
| Pathway | REACTOME_MET_PROMOTES_CELL_MOTILITY | 1.09e-06 | 41 | 64 | 5 | M27778 | |
| Pathway | REACTOME_INTEGRIN_CELL_SURFACE_INTERACTIONS | 1.18e-06 | 76 | 64 | 6 | MM14867 | |
| Pathway | REACTOME_MET_ACTIVATES_PTK2_SIGNALING | 1.42e-06 | 19 | 64 | 4 | MM15512 | |
| Pathway | REACTOME_SCAVENGING_BY_CLASS_A_RECEPTORS | 1.42e-06 | 19 | 64 | 4 | M27221 | |
| Pathway | REACTOME_INTEGRIN_CELL_SURFACE_INTERACTIONS | 2.28e-06 | 85 | 64 | 6 | M16441 | |
| Pathway | REACTOME_DEGRADATION_OF_THE_EXTRACELLULAR_MATRIX | 3.18e-06 | 140 | 64 | 7 | M587 | |
| Pathway | REACTOME_SYNDECAN_INTERACTIONS | 6.27e-06 | 27 | 64 | 4 | M27217 | |
| Pathway | REACTOME_NON_INTEGRIN_MEMBRANE_ECM_INTERACTIONS | 6.82e-06 | 59 | 64 | 5 | M27218 | |
| Pathway | REACTOME_EXTRACELLULAR_MATRIX_ORGANIZATION | COL3A1 COL4A6 COL5A2 COL24A1 COL7A1 FBLN2 COL17A1 COL1A1 COL1A2 | 7.83e-06 | 300 | 64 | 9 | M610 |
| Pathway | REACTOME_MET_PROMOTES_CELL_MOTILITY | 9.69e-06 | 30 | 64 | 4 | MM15517 | |
| Pathway | REACTOME_DEGRADATION_OF_THE_EXTRACELLULAR_MATRIX | 1.25e-05 | 114 | 64 | 6 | MM14571 | |
| Pathway | REACTOME_EXTRACELLULAR_MATRIX_ORGANIZATION | 2.06e-05 | 258 | 64 | 8 | MM14572 | |
| Pathway | REACTOME_ECM_PROTEOGLYCANS | 2.37e-05 | 76 | 64 | 5 | M27219 | |
| Pathway | REACTOME_SIGNALING_BY_MET | 2.86e-05 | 79 | 64 | 5 | M27643 | |
| Pathway | REACTOME_NCAM1_INTERACTIONS | 3.80e-05 | 42 | 64 | 4 | M7169 | |
| Pathway | KEGG_ECM_RECEPTOR_INTERACTION | 3.85e-05 | 84 | 64 | 5 | M7098 | |
| Pathway | REACTOME_ECM_PROTEOGLYCANS | 5.95e-05 | 47 | 64 | 4 | MM14925 | |
| Pathway | REACTOME_CROSSLINKING_OF_COLLAGEN_FIBRILS | 6.94e-05 | 18 | 64 | 3 | M27164 | |
| Pathway | REACTOME_CROSSLINKING_OF_COLLAGEN_FIBRILS | 6.94e-05 | 18 | 64 | 3 | MM14882 | |
| Pathway | WP_OSTEOARTHRITIC_CHONDROCYTE_HYPERTROPHY | 7.61e-05 | 50 | 64 | 4 | M48087 | |
| Pathway | REACTOME_NCAM_SIGNALING_FOR_NEURITE_OUT_GROWTH | 1.88e-04 | 63 | 64 | 4 | M11187 | |
| Pathway | WP_FOCAL_ADHESION | 1.99e-04 | 187 | 64 | 6 | MM15913 | |
| Pathway | REACTOME_SIGNALING_BY_MET | 2.39e-04 | 67 | 64 | 4 | MM15345 | |
| Pathway | WP_DYSREGULATED_MIRNA_TARGETING_IN_INSULINPI3KAKT_SIGNALING | 2.70e-04 | 28 | 64 | 3 | MM15957 | |
| Pathway | KEGG_FOCAL_ADHESION | 2.79e-04 | 199 | 64 | 6 | M7253 | |
| Pathway | WP_INFLAMMATORY_RESPONSE_PATHWAY | 3.32e-04 | 30 | 64 | 3 | M39641 | |
| Pathway | WP_INFLAMMATORY_RESPONSE_PATHWAY | 3.32e-04 | 30 | 64 | 3 | MM15812 | |
| Pathway | REACTOME_ENHANCED_BINDING_OF_GP1BA_VARIANT_TO_VWF_MULTIMER_COLLAGEN | 4.20e-04 | 7 | 64 | 2 | M48265 | |
| Pathway | REACTOME_DEFECTS_OF_PLATELET_ADHESION_TO_EXPOSED_COLLAGEN | 5.58e-04 | 8 | 64 | 2 | M48236 | |
| Pathway | PID_FRA_PATHWAY | 6.21e-04 | 37 | 64 | 3 | M65 | |
| Pathway | REACTOME_NGF_STIMULATED_TRANSCRIPTION | 7.26e-04 | 39 | 64 | 3 | M29793 | |
| Pathway | WP_CORTICOTROPINRELEASING_HORMONE_SIGNALING | 8.00e-04 | 92 | 64 | 4 | M39441 | |
| Pathway | WP_MIRNA_TARGETS_IN_ECM_AND_MEMBRANE_RECEPTORS | 9.68e-04 | 43 | 64 | 3 | M39565 | |
| Pathway | PID_INTEGRIN3_PATHWAY | 9.68e-04 | 43 | 64 | 3 | M53 | |
| Pathway | REACTOME_BINDING_AND_UPTAKE_OF_LIGANDS_BY_SCAVENGER_RECEPTORS | 1.01e-03 | 98 | 64 | 4 | M27152 | |
| Pathway | REACTOME_GP1B_IX_V_ACTIVATION_SIGNALLING | 1.30e-03 | 12 | 64 | 2 | MM15093 | |
| Pathway | REACTOME_GP1B_IX_V_ACTIVATION_SIGNALLING | 1.30e-03 | 12 | 64 | 2 | M27352 | |
| Pathway | REACTOME_PLATELET_ADHESION_TO_EXPOSED_COLLAGEN | 1.30e-03 | 12 | 64 | 2 | MM15452 | |
| Pathway | WP_PHOSPHODIESTERASES_IN_NEURONAL_FUNCTION | 1.98e-03 | 55 | 64 | 3 | M39763 | |
| Pathway | WP_FOCAL_ADHESION | 2.07e-03 | 199 | 64 | 5 | M39402 | |
| Pathway | REACTOME_PLATELET_ADHESION_TO_EXPOSED_COLLAGEN | 2.34e-03 | 16 | 64 | 2 | M9450 | |
| Pathway | REACTOME_NUCLEAR_EVENTS_KINASE_AND_TRANSCRIPTION_FACTOR_ACTIVATION | 2.66e-03 | 61 | 64 | 3 | M152 | |
| Pathway | REACTOME_SIGNALING_BY_RECEPTOR_TYROSINE_KINASES | 2.69e-03 | 532 | 64 | 8 | M27870 | |
| Pathway | WP_MIR5093P_ALTERATION_OF_YAP1ECM_AXIS | 2.96e-03 | 18 | 64 | 2 | M39421 | |
| Pathway | PID_CD8_TCR_DOWNSTREAM_PATHWAY | 3.19e-03 | 65 | 64 | 3 | M272 | |
| Pathway | REACTOME_IMMUNOREGULATORY_INTERACTIONS_BETWEEN_A_LYMPHOID_AND_A_NON_LYMPHOID_CELL | 3.28e-03 | 135 | 64 | 4 | MM14781 | |
| Pathway | REACTOME_DISEASES_OF_HEMOSTASIS | 3.30e-03 | 19 | 64 | 2 | M48230 | |
| Pathway | REACTOME_NCAM1_INTERACTIONS | 3.66e-03 | 20 | 64 | 2 | MM15061 | |
| Pathway | WP_UROTENSINIIMEDIATED_SIGNALING | 3.78e-03 | 69 | 64 | 3 | M48052 | |
| Pathway | PID_AP1_PATHWAY | 3.93e-03 | 70 | 64 | 3 | M167 | |
| Pubmed | A census of human transcription factors: function, expression and evolution. | JUNB KLF1 BARHL1 GLI2 PITX3 ELK1 NKX2-6 ZFPM1 ZNF385A TSC22D2 FOXI3 RAX GSC2 CIC TLX2 FOSL1 FOXC2 | 2.82e-11 | 908 | 81 | 17 | 19274049 |
| Pubmed | COL3A1 COL4A6 COL5A2 COL24A1 COL7A1 FBLN2 COL17A1 COL1A1 COL1A2 | 9.69e-11 | 153 | 81 | 9 | 25037231 | |
| Pubmed | Proteomic characterization of human multiple myeloma bone marrow extracellular matrix. | 1.26e-10 | 62 | 81 | 7 | 28344315 | |
| Pubmed | 1.36e-10 | 5 | 81 | 4 | 15365990 | ||
| Pubmed | 1.90e-09 | 8 | 81 | 4 | 18816857 | ||
| Pubmed | 5.67e-09 | 10 | 81 | 4 | 14559231 | ||
| Pubmed | 5.70e-09 | 167 | 81 | 8 | 22159717 | ||
| Pubmed | 8.23e-09 | 175 | 81 | 8 | 28071719 | ||
| Pubmed | 1.22e-08 | 3 | 81 | 3 | 34205850 | ||
| Pubmed | Coordinate patterns of expression of type I and III collagens during mouse development. | 1.22e-08 | 3 | 81 | 3 | 8785585 | |
| Pubmed | Differential expression of type I and type III collagen genes during tooth development. | 1.22e-08 | 3 | 81 | 3 | 1879336 | |
| Pubmed | 1.22e-08 | 3 | 81 | 3 | 17662583 | ||
| Pubmed | Loss of flow responsive Tie1 results in Impaired
Aortic valve remodeling. | 2.68e-08 | 14 | 81 | 4 | 31319059 | |
| Pubmed | Characterization of the Extracellular Matrix of Normal and Diseased Tissues Using Proteomics. | 3.11e-08 | 135 | 81 | 7 | 28675934 | |
| Pubmed | 4.86e-08 | 4 | 81 | 3 | 12874293 | ||
| Pubmed | Localization of types I and III collagen and fibronectin in the developing mouse palatal shelves. | 4.86e-08 | 4 | 81 | 3 | 8984825 | |
| Pubmed | 4.86e-08 | 4 | 81 | 3 | 19932771 | ||
| Pubmed | 4.86e-08 | 4 | 81 | 3 | 24361166 | ||
| Pubmed | 4.86e-08 | 4 | 81 | 3 | 1409674 | ||
| Pubmed | 4.86e-08 | 4 | 81 | 3 | 8686743 | ||
| Pubmed | 4.86e-08 | 4 | 81 | 3 | 33974636 | ||
| Pubmed | 4.86e-08 | 16 | 81 | 4 | 17881772 | ||
| Pubmed | Impact of cytosine methylation on DNA binding specificities of human transcription factors. | JUNB BARHL1 GLI2 PITX3 ELK1 ZBTB12 RAX GSC2 TLX2 FOSL1 FOXC2 | 5.60e-08 | 544 | 81 | 11 | 28473536 |
| Pubmed | 1.18e-07 | 50 | 81 | 5 | 23658023 | ||
| Pubmed | 1.21e-07 | 5 | 81 | 3 | 18211825 | ||
| Pubmed | Collagen and tenascin-C expression along the migration pathway of mouse primordial germ cells. | 1.21e-07 | 5 | 81 | 3 | 14758483 | |
| Pubmed | Extracellular matrix protein expression during mouse detrusor development. | 1.21e-07 | 5 | 81 | 3 | 12592609 | |
| Pubmed | 1.29e-07 | 20 | 81 | 4 | 38113115 | ||
| Pubmed | ColVa1 and ColXIa1 are required for myocardial morphogenesis and heart valve development. | 2.42e-07 | 6 | 81 | 3 | 17029294 | |
| Pubmed | 2.42e-07 | 6 | 81 | 3 | 15514164 | ||
| Pubmed | 2.42e-07 | 6 | 81 | 3 | 17135260 | ||
| Pubmed | 2.42e-07 | 6 | 81 | 3 | 9101290 | ||
| Pubmed | 3.33e-07 | 25 | 81 | 4 | 19180518 | ||
| Pubmed | 4.23e-07 | 7 | 81 | 3 | 21558934 | ||
| Pubmed | 4.23e-07 | 7 | 81 | 3 | 23273220 | ||
| Pubmed | COL5A2 COL24A1 JUNB UBN1 INPPL1 DENND4B MAML2 ZNF385A CIC COL1A2 FOXC2 | 5.88e-07 | 689 | 81 | 11 | 36543142 | |
| Pubmed | 6.76e-07 | 8 | 81 | 3 | 1377218 | ||
| Pubmed | 3D Mapping Reveals a Complex and Transient Interstitial Matrix During Murine Kidney Development. | 6.76e-07 | 8 | 81 | 3 | 33875569 | |
| Pubmed | 7.14e-07 | 30 | 81 | 4 | 36460641 | ||
| Pubmed | Fgf10 deficiency is causative for lethality in a mouse model of bronchopulmonary dysplasia. | 9.34e-07 | 32 | 81 | 4 | 27770432 | |
| Pubmed | Loss of ADAMTS19 causes progressive non-syndromic heart valve disease. | 1.01e-06 | 9 | 81 | 3 | 31844321 | |
| Pubmed | 1.01e-06 | 9 | 81 | 3 | 9878537 | ||
| Pubmed | 1.01e-06 | 9 | 81 | 3 | 8900172 | ||
| Pubmed | 1.06e-06 | 33 | 81 | 4 | 18424556 | ||
| Pubmed | 1.44e-06 | 10 | 81 | 3 | 20864640 | ||
| Pubmed | Regulation of steatohepatitis and PPARγ signaling by distinct AP-1 dimers. | 1.44e-06 | 10 | 81 | 3 | 24411941 | |
| Pubmed | A dual-activity topoisomerase complex regulates mRNA translation and turnover. | JUNB NCOA6 ABCA2 UBN1 MEGF8 SZT2 INPPL1 CACNA1H ZFPM1 GRIN2D ESPL1 CIC COL1A1 | 1.59e-06 | 1105 | 81 | 13 | 35748872 |
| Pubmed | Comprehensive proteomic characterization of stem cell-derived extracellular matrices. | 1.82e-06 | 86 | 81 | 5 | 28327460 | |
| Pubmed | Epicardial cell shape and maturation are regulated by Wt1 via transcriptional control of Bmp4. | 1.90e-06 | 38 | 81 | 4 | 31624071 | |
| Pubmed | 1.92e-06 | 87 | 81 | 5 | 20548288 | ||
| Pubmed | The atypical homeodomain transcription factor Mohawk controls tendon morphogenesis. | 1.98e-06 | 11 | 81 | 3 | 20696843 | |
| Pubmed | 2.11e-06 | 39 | 81 | 4 | 30566624 | ||
| Pubmed | 2.35e-06 | 638 | 81 | 10 | 31182584 | ||
| Pubmed | 2.64e-06 | 12 | 81 | 3 | 7993390 | ||
| Pubmed | 3.19e-06 | 268 | 81 | 7 | 33640491 | ||
| Pubmed | Glycoproteomics Reveals Decorin Peptides With Anti-Myostatin Activity in Human Atrial Fibrillation. | 3.29e-06 | 97 | 81 | 5 | 27559042 | |
| Pubmed | EGR1 and EGR2 involvement in vertebrate tendon differentiation. | 3.42e-06 | 13 | 81 | 3 | 21173153 | |
| Pubmed | The Mohawk homeobox gene is a critical regulator of tendon differentiation. | 3.42e-06 | 13 | 81 | 3 | 20498044 | |
| Pubmed | 4.02e-06 | 529 | 81 | 9 | 14621295 | ||
| Pubmed | 4.35e-06 | 14 | 81 | 3 | 28809397 | ||
| Pubmed | The transcription factor Foxc1 is necessary for Ihh-Gli2-regulated endochondral ossification. | 4.35e-06 | 14 | 81 | 3 | 25808752 | |
| Pubmed | 4.35e-06 | 14 | 81 | 3 | 29593327 | ||
| Pubmed | 5.36e-06 | 2 | 81 | 2 | 11358497 | ||
| Pubmed | 5.36e-06 | 2 | 81 | 2 | 11143996 | ||
| Pubmed | 5.36e-06 | 2 | 81 | 2 | 35964930 | ||
| Pubmed | 5.36e-06 | 2 | 81 | 2 | 15211650 | ||
| Pubmed | 5.36e-06 | 2 | 81 | 2 | 35915937 | ||
| Pubmed | 5.36e-06 | 2 | 81 | 2 | 27636223 | ||
| Pubmed | 5.36e-06 | 2 | 81 | 2 | 32335875 | ||
| Pubmed | 5.36e-06 | 2 | 81 | 2 | 14988077 | ||
| Pubmed | [Analysis of COL1A1 and COL1A2 gene variants in two fetuses with osteogenesis imperfecta]. | 5.36e-06 | 2 | 81 | 2 | 37368383 | |
| Pubmed | Osteogenesis imperfecta: comparison of molecular defects with bone histological changes. | 5.36e-06 | 2 | 81 | 2 | 7520724 | |
| Pubmed | 5.36e-06 | 2 | 81 | 2 | 8723681 | ||
| Pubmed | Unequal Impact of COL1A1 and COL1A2 Variants on Dentinogenesis Imperfecta. | 5.36e-06 | 2 | 81 | 2 | 36951356 | |
| Pubmed | 5.36e-06 | 2 | 81 | 2 | 17211858 | ||
| Pubmed | 5.36e-06 | 2 | 81 | 2 | 5529814 | ||
| Pubmed | 5.36e-06 | 2 | 81 | 2 | 21622683 | ||
| Pubmed | 5.36e-06 | 2 | 81 | 2 | 9443882 | ||
| Pubmed | 5.36e-06 | 2 | 81 | 2 | 6324198 | ||
| Pubmed | Collagen I and collagen III polymorphisms in women with pelvic organ prolapse. | 5.36e-06 | 2 | 81 | 2 | 32692893 | |
| Pubmed | 5.36e-06 | 2 | 81 | 2 | 15241796 | ||
| Pubmed | Mutation spectrum of COL1A1 and COL1A2 genes in Indian patients with osteogenesis imperfecta. | 5.36e-06 | 2 | 81 | 2 | 24668929 | |
| Pubmed | Prenatal Cases Reflect the Complexity of the COL1A1/2 Associated Osteogenesis Imperfecta. | 5.36e-06 | 2 | 81 | 2 | 36140746 | |
| Pubmed | 5.36e-06 | 2 | 81 | 2 | 16521042 | ||
| Pubmed | 5.36e-06 | 2 | 81 | 2 | 7945553 | ||
| Pubmed | Differential expression of procollagen genes between mid- and late-gestational fetal fibroblasts. | 5.36e-06 | 2 | 81 | 2 | 19560165 | |
| Pubmed | [Relationship of collagen type I alpha 1 and alpha 2 gene polymorphisms with bone mineral density]. | 5.36e-06 | 2 | 81 | 2 | 16864092 | |
| Pubmed | Evidence for a relationship between Ehlers-Danlos type VII C in humans and bovine dermatosparaxis. | 5.36e-06 | 2 | 81 | 2 | 1303238 | |
| Pubmed | 5.36e-06 | 2 | 81 | 2 | 20087402 | ||
| Pubmed | Collagen synthesis is not altered in women with stress urinary incontinence. | 5.36e-06 | 2 | 81 | 2 | 15227656 | |
| Pubmed | 5.36e-06 | 2 | 81 | 2 | 20685979 | ||
| Pubmed | Early type I collagen deposition is associated with prognosis in biliary atresia. | 5.36e-06 | 2 | 81 | 2 | 26452701 | |
| Pubmed | 5.36e-06 | 2 | 81 | 2 | 8097422 | ||
| Pubmed | Regional chromosome mapping of human collagen genes alpha 2(I) and alpha 1(I) (COLIA2 and COLIA1). | 5.36e-06 | 2 | 81 | 2 | 3857213 | |
| Pubmed | 5.36e-06 | 2 | 81 | 2 | 34902613 | ||
| Pubmed | 5.36e-06 | 2 | 81 | 2 | 1874719 | ||
| Pubmed | Clinical severity prediction in children with osteogenesis imperfecta caused by COL1A1/2 defects. | 5.36e-06 | 2 | 81 | 2 | 35044492 | |
| Pubmed | Differential unfolding of alpha1 and alpha2 chains in type I collagen and collagenolysis. | 5.36e-06 | 2 | 81 | 2 | 18644377 | |
| Pubmed | 5.36e-06 | 2 | 81 | 2 | 23040566 | ||
| Pubmed | COL1 C-propeptide cleavage site mutations cause high bone mass osteogenesis imperfecta. | 5.36e-06 | 2 | 81 | 2 | 21344539 | |
| Interaction | LAIR2 interactions | 1.44e-06 | 49 | 80 | 5 | int:LAIR2 | |
| Interaction | MMP2 interactions | 2.49e-05 | 87 | 80 | 5 | int:MMP2 | |
| Interaction | TMEM44 interactions | 2.65e-05 | 15 | 80 | 3 | int:TMEM44 | |
| Interaction | CD93 interactions | 3.03e-05 | 45 | 80 | 4 | int:CD93 | |
| Interaction | PRMT2 interactions | 3.09e-05 | 91 | 80 | 5 | int:PRMT2 | |
| Interaction | PAX3 interactions | 5.39e-05 | 52 | 80 | 4 | int:PAX3 | |
| Cytoband | 19p13.2 | 7.43e-04 | 229 | 81 | 4 | 19p13.2 | |
| Cytoband | 11q13 | 1.22e-03 | 118 | 81 | 3 | 11q13 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr1p34 | 1.86e-03 | 294 | 81 | 4 | chr1p34 | |
| Cytoband | 3p21.1 | 2.53e-03 | 42 | 81 | 2 | 3p21.1 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr2q14 | 3.17e-03 | 165 | 81 | 3 | chr2q14 | |
| Cytoband | 6p21.33 | 3.57e-03 | 50 | 81 | 2 | 6p21.33 | |
| GeneFamily | Collagens | 2.82e-12 | 46 | 62 | 8 | 490 | |
| GeneFamily | NKL subclass homeoboxes and pseudogenes | 1.57e-03 | 67 | 62 | 3 | 519 | |
| GeneFamily | Phosphodiesterases | 3.04e-03 | 24 | 62 | 2 | 681 | |
| GeneFamily | Sterile alpha motif domain containing | 3.43e-03 | 88 | 62 | 3 | 760 | |
| GeneFamily | Calcium voltage-gated channel subunits | 3.57e-03 | 26 | 62 | 2 | 253 | |
| GeneFamily | PRD class homeoboxes and pseudogenes | 3.88e-03 | 92 | 62 | 3 | 521 | |
| Coexpression | NABA_COLLAGENS | 7.75e-13 | 43 | 81 | 8 | MM17060 | |
| Coexpression | NABA_COLLAGENS | 9.45e-13 | 44 | 81 | 8 | M3005 | |
| Coexpression | BENPORATH_ES_WITH_H3K27ME3 | COL4A6 COL24A1 DRD5 RGS20 HCN4 MAP6 BARHL1 SLC10A4 PITX3 ELAVL3 CACNA1G ZFPM1 GRIN2D REPS2 RAX GSC2 TLX2 | 4.25e-08 | 1115 | 81 | 17 | M10371 |
| Coexpression | BENPORATH_SUZ12_TARGETS | COL4A6 COL24A1 DRD5 RGS20 HCN4 MAP6 BARHL1 SLC10A4 PITX3 ELAVL3 CACNA1G GRIN2D REPS2 RAX GSC2 TLX2 | 9.37e-08 | 1035 | 81 | 16 | M9898 |
| Coexpression | NABA_CORE_MATRISOME | COL3A1 COL4A6 COL5A2 COL24A1 COL7A1 FBLN2 COL17A1 COL1A1 COL1A2 | 1.56e-07 | 270 | 81 | 9 | MM17057 |
| Coexpression | NABA_CORE_MATRISOME | COL3A1 COL4A6 COL5A2 COL24A1 COL7A1 FBLN2 COL17A1 COL1A1 COL1A2 | 1.82e-07 | 275 | 81 | 9 | M5884 |
| Coexpression | BENPORATH_PRC2_TARGETS | COL4A6 COL24A1 DRD5 RGS20 BARHL1 SLC10A4 PITX3 CACNA1G REPS2 RAX GSC2 TLX2 | 7.26e-07 | 650 | 81 | 12 | M8448 |
| Coexpression | ESC_V6.5_UP_EARLY.V1_DN | 7.47e-07 | 163 | 81 | 7 | M2769 | |
| Coexpression | FOROUTAN_INTEGRATED_TGFB_EMT_UP | 1.99e-06 | 120 | 81 | 6 | M42505 | |
| Coexpression | HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION | 2.92e-06 | 200 | 81 | 7 | M5930 | |
| Coexpression | TURASHVILI_BREAST_DUCTAL_CARCINOMA_VS_LOBULAR_NORMAL_UP | 3.39e-06 | 74 | 81 | 5 | M4479 | |
| Coexpression | TRAVAGLINI_LUNG_ADVENTITIAL_FIBROBLAST_CELL | 3.79e-06 | 296 | 81 | 8 | M41675 | |
| Coexpression | NABA_MATRISOME_PRIMARY_METASTATIC_LUNG_TUMOR | 4.12e-06 | 35 | 81 | 4 | MM17054 | |
| Coexpression | CLASPER_LYMPHATIC_VESSELS_DURING_METASTASIS_DN | 4.12e-06 | 35 | 81 | 4 | M11788 | |
| Coexpression | CLASPER_LYMPHATIC_VESSELS_DURING_METASTASIS_DN | 4.62e-06 | 36 | 81 | 4 | MM1212 | |
| Coexpression | ZHU_CMV_24_HR_DN | 6.34e-06 | 84 | 81 | 5 | M4065 | |
| Coexpression | HUMMERICH_SKIN_CANCER_PROGRESSION_UP | 7.97e-06 | 88 | 81 | 5 | M1167 | |
| Coexpression | TURASHVILI_BREAST_DUCTAL_CARCINOMA_VS_DUCTAL_NORMAL_UP | 1.36e-05 | 47 | 81 | 4 | M7585 | |
| Coexpression | GSE24671_CTRL_VS_BAKIMULC_INFECTED_MOUSE_SPLENOCYTES_DN | 1.48e-05 | 170 | 81 | 6 | M9445 | |
| Coexpression | HUMMERICH_SKIN_CANCER_PROGRESSION_UP | 1.49e-05 | 100 | 81 | 5 | MM514 | |
| Coexpression | SASAI_RESISTANCE_TO_NEOPLASTIC_TRANSFROMATION | 1.75e-05 | 50 | 81 | 4 | M1259 | |
| Coexpression | SASAI_RESISTANCE_TO_NEOPLASTIC_TRANSFROMATION | 2.05e-05 | 52 | 81 | 4 | MM1118 | |
| Coexpression | THUM_MIR21_TARGETS_HEART_DISEASE_UP | 2.24e-05 | 18 | 81 | 3 | MM1241 | |
| Coexpression | THUM_MIR21_TARGETS_HEART_DISEASE_UP | 2.24e-05 | 18 | 81 | 3 | M13796 | |
| Coexpression | FARMER_BREAST_CANCER_CLUSTER_4 | 2.66e-05 | 19 | 81 | 3 | M15125 | |
| Coexpression | FOROUTAN_TGFB_EMT_UP | 2.94e-05 | 192 | 81 | 6 | M42501 | |
| Coexpression | AIZARANI_LIVER_C21_STELLATE_CELLS_1 | 3.11e-05 | 194 | 81 | 6 | M39122 | |
| Coexpression | ZHU_CMV_ALL_DN | 3.45e-05 | 119 | 81 | 5 | M14555 | |
| Coexpression | GSE18281_SUBCAPSULAR_CORTICAL_REGION_VS_WHOLE_MEDULLA_THYMUS_UP | 3.59e-05 | 199 | 81 | 6 | M7254 | |
| Coexpression | WILCOX_RESPONSE_TO_PROGESTERONE_DN | 4.12e-05 | 62 | 81 | 4 | M16774 | |
| Coexpression | ANASTASSIOU_MULTICANCER_INVASIVENESS_SIGNATURE | 4.67e-05 | 64 | 81 | 4 | M2572 | |
| Coexpression | CUI_DEVELOPING_HEART_COMPACT_VENTRICULAR_CARDIOMYOCYTE | 4.96e-05 | 65 | 81 | 4 | M39309 | |
| Coexpression | RAMASWAMY_METASTASIS_UP | 5.27e-05 | 66 | 81 | 4 | M6698 | |
| Coexpression | GOTZMANN_EPITHELIAL_TO_MESENCHYMAL_TRANSITION_UP | 5.93e-05 | 68 | 81 | 4 | M1373 | |
| Coexpression | TURASHVILI_BREAST_LOBULAR_CARCINOMA_VS_DUCTAL_NORMAL_UP | 6.28e-05 | 69 | 81 | 4 | M10165 | |
| Coexpression | DESCARTES_FETAL_THYMUS_STROMAL_CELLS | 6.75e-05 | 137 | 81 | 5 | M40313 | |
| Coexpression | GOTZMANN_EPITHELIAL_TO_MESENCHYMAL_TRANSITION_UP | 7.42e-05 | 72 | 81 | 4 | MM1131 | |
| Coexpression | TURASHVILI_BREAST_LOBULAR_CARCINOMA_VS_LOBULAR_NORMAL_DN | 8.26e-05 | 74 | 81 | 4 | M13547 | |
| Coexpression | IGLESIAS_E2F_TARGETS_UP | 8.55e-05 | 144 | 81 | 5 | M1484 | |
| Coexpression | BENPORATH_EED_TARGETS | COL4A6 COL24A1 DRD5 RGS20 BARHL1 SLC10A4 PITX3 CACNA1G REPS2 RAX GSC2 TLX2 | 9.61e-05 | 1059 | 81 | 12 | M7617 |
| Coexpression | IGLESIAS_E2F_TARGETS_UP | 9.73e-05 | 148 | 81 | 5 | MM1010 | |
| Coexpression | NABA_MATRISOME_METASTATIC_LUNG_LYMPH_NODE_METASTASIS | 9.80e-05 | 29 | 81 | 3 | MM17055 | |
| Coexpression | NAKAMURA_CANCER_MICROENVIRONMENT_UP | 9.80e-05 | 29 | 81 | 3 | M7581 | |
| Coexpression | HE_LIM_SUN_FETAL_LUNG_C1_MID_BASAL_CELL | 1.00e-04 | 149 | 81 | 5 | M45703 | |
| Coexpression | UDAYAKUMAR_MED1_TARGETS_DN | 1.11e-04 | 244 | 81 | 6 | M9945 | |
| Coexpression | MENON_FETAL_KIDNEY_3_STROMAL_CELLS | 1.18e-04 | 81 | 81 | 4 | M39253 | |
| Coexpression | HEBERT_MATRISOME_TNBC_LUNG_METASTASIS_TUMOR_CELL_DERIVED | 1.40e-04 | 6 | 81 | 2 | M48000 | |
| Coexpression | KIM_GLIS2_TARGETS_UP | 1.48e-04 | 86 | 81 | 4 | M2259 | |
| Coexpression | GSE6269_FLU_VS_E_COLI_INF_PBMC_UP | 1.57e-04 | 164 | 81 | 5 | M5653 | |
| Coexpression | MEBARKI_HCC_PROGENITOR_WNT_UP_CTNNB1_DEPENDENT | 1.77e-04 | 90 | 81 | 4 | M38984 | |
| Coexpression | DESCARTES_FETAL_EYE_STROMAL_CELLS | 1.84e-04 | 91 | 81 | 4 | M40180 | |
| Coexpression | WATANABE_RECTAL_CANCER_RADIOTHERAPY_RESPONSIVE_DN | 2.01e-04 | 93 | 81 | 4 | M4752 | |
| Coexpression | DESCARTES_FETAL_MUSCLE_STROMAL_CELLS | 2.55e-04 | 99 | 81 | 4 | M40255 | |
| Coexpression | GAO_LARGE_INTESTINE_24W_C1_DCLK1POS_PROGENITOR | 2.55e-04 | 99 | 81 | 4 | M39152 | |
| Coexpression | LEE_AGING_MUSCLE_DN | 2.59e-04 | 40 | 81 | 3 | M1574 | |
| Coexpression | KIM_GLIS2_TARGETS_UP | 2.86e-04 | 102 | 81 | 4 | MM1064 | |
| Coexpression | DURAND_STROMA_S_UP | 3.38e-04 | 300 | 81 | 6 | M2581 | |
| Coexpression | VANHARANTA_UTERINE_FIBROID_UP | 3.44e-04 | 44 | 81 | 3 | M18274 | |
| Coexpression | DURAND_STROMA_S_UP | 3.63e-04 | 304 | 81 | 6 | MM1083 | |
| Coexpression | SUNG_METASTASIS_STROMA_UP | 3.81e-04 | 110 | 81 | 4 | M9483 | |
| Coexpression | GSE33374_CD8_ALPHAALPHA_VS_ALPHABETA_CD161_HIGH_TCELL_UP | 3.85e-04 | 199 | 81 | 5 | M8538 | |
| Coexpression | JONES_OVARY_THECA | 3.92e-04 | 46 | 81 | 3 | M48349 | |
| Coexpression | LEE_AGING_MUSCLE_DN | 3.92e-04 | 46 | 81 | 3 | MM670 | |
| Coexpression | KHETCHOUMIAN_TRIM24_TARGETS_UP | 3.92e-04 | 46 | 81 | 3 | MM544 | |
| Coexpression | GSE40655_FOXO1_KO_VS_WT_NTREG_UP | 3.94e-04 | 200 | 81 | 5 | M9439 | |
| Coexpression | GSE43955_10H_VS_60H_ACT_CD4_TCELL_DN | 3.94e-04 | 200 | 81 | 5 | M9692 | |
| Coexpression | GSE27434_WT_VS_DNMT1_KO_TREG_DN | 3.94e-04 | 200 | 81 | 5 | M9621 | |
| Coexpression | GSE19772_HCMV_INFL_VS_HCMV_INF_MONOCYTES_AND_PI3K_INHIBITION_UP | 3.94e-04 | 200 | 81 | 5 | M7283 | |
| Coexpression | GSE46606_DAY1_VS_DAY3_CD40L_IL2_IL5_STIMULATED_IRF4_KO_BCELL_UP | 3.94e-04 | 200 | 81 | 5 | M9825 | |
| Coexpression | KHETCHOUMIAN_TRIM24_TARGETS_UP | 4.18e-04 | 47 | 81 | 3 | M1399 | |
| Coexpression | CUI_DEVELOPING_HEART_SMOOTH_MUSCLE_CELL | 4.45e-04 | 48 | 81 | 3 | M39318 | |
| Coexpression | CUI_DEVELOPING_HEART_C3_FIBROBLAST_LIKE_CELL | 4.81e-04 | 117 | 81 | 4 | M39300 | |
| Coexpression | ROY_WOUND_BLOOD_VESSEL_UP | 5.02e-04 | 50 | 81 | 3 | M7337 | |
| Coexpression | DELACROIX_RAR_BOUND_ES | 5.94e-04 | 465 | 81 | 7 | M2466 | |
| Coexpression | ZHANG_UTERUS_C2_SECRETORY_STROMAL3_RAMP3_HIGH_CELL | 7.28e-04 | 229 | 81 | 5 | MM16607 | |
| Coexpression | BENPORATH_MYC_TARGETS_WITH_EBOX | 7.42e-04 | 230 | 81 | 5 | M27 | |
| Coexpression | CROMER_TUMORIGENESIS_UP | 7.76e-04 | 58 | 81 | 3 | M178 | |
| Coexpression | HE_LIM_SUN_FETAL_LUNG_C3_OMD_POS_ENDOTHELIAL_CELL | 8.18e-04 | 355 | 81 | 6 | M45758 | |
| Coexpression | PEREZ_TP63_TARGETS | 8.30e-04 | 356 | 81 | 6 | M10761 | |
| Coexpression | DELACROIX_RAR_BOUND_ES | 8.37e-04 | 493 | 81 | 7 | MM1079 | |
| Coexpression | SENESE_HDAC1_AND_HDAC2_TARGETS_DN | 8.65e-04 | 238 | 81 | 5 | M12004 | |
| Coexpression | POMEROY_MEDULLOBLASTOMA_DESMOPLASIC_VS_CLASSIC_DN | 8.99e-04 | 61 | 81 | 3 | M8510 | |
| CoexpressionAtlas | FacebaseRNAseq_e9.5_Maxillary Arch_top-relative-expression-ranked_1000_k-means-cluster#1 | 1.07e-05 | 371 | 80 | 9 | Facebase_RNAseq_e9.5_Maxillary Arch_1000_K1 | |
| CoexpressionAtlas | ratio_EmbryoidBody_vs_StemCell_top-relative-expression-ranked_2500_k-means-cluster#3 | SHANK1 COL3A1 COL5A2 FBLN2 MAP6 BARHL1 ELAVL3 MAML2 MN1 SH3RF3 TLX2 PDE11A COL1A1 COL1A2 FOXC2 | 1.23e-05 | 1094 | 80 | 15 | ratio_EB_vs_SC_2500_K3 |
| CoexpressionAtlas | FacebaseRNAseq_ratio_e9.5_MandibularArch_vs_MaxillaryArch_top-relative-expression-ranked_1000_k-means-cluster#2 | 1.36e-05 | 290 | 80 | 8 | Facebase_RNAseq_ratio_e9.5_MandibularArch_vs_MaxillaryArch_1000_K2 | |
| CoexpressionAtlas | FacebaseRNAseq_ratio_e9.5_MandibularArch_vs_MaxillaryArch_top-relative-expression-ranked_1000 | SHANK1 COL3A1 COL24A1 COL7A1 ABCA2 FBLN2 COL17A1 CACNA1H CACNA1G REPS2 SH3RF3 ACSS3 COL1A1 COL1A2 | 1.37e-05 | 967 | 80 | 14 | Facebase_RNAseq_ratio_e9.5_MandibularArch_vs_MaxillaryArch_1000 |
| CoexpressionAtlas | FacebaseRNAseq_e8.5_Paraxial Mesoderm_top-relative-expression-ranked_1000 | SHANK1 COL3A1 COL24A1 COL7A1 ABCA2 FBLN2 COL17A1 CACNA1H CACNA1G REPS2 SH3RF3 ACSS3 COL1A1 COL1A2 | 1.37e-05 | 967 | 80 | 14 | Facebase_RNAseq_e8.5_Paraxial Mesoderm_1000 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Maxillary Arch_top-relative-expression-ranked_2500_k-means-cluster#4 | COL24A1 COL7A1 FBLN2 COL17A1 KLF1 CACNA1G REPS2 SH3RF3 ACSS3 COL1A1 COL1A2 | 3.36e-05 | 655 | 80 | 11 | Facebase_RNAseq_e10.5_Maxillary Arch_2500_K4 |
| CoexpressionAtlas | FacebaseRNAseq_e8.5_Paraxial Mesoderm_top-relative-expression-ranked_1000_k-means-cluster#2 | 3.43e-05 | 330 | 80 | 8 | Facebase_RNAseq_e8.5_Paraxial Mesoderm_1000_K2 | |
| CoexpressionAtlas | FacebaseRNAseq_e8.5_Paraxial Mesoderm_top-relative-expression-ranked_500_k-means-cluster#3 | 4.30e-05 | 249 | 80 | 7 | Facebase_RNAseq_e8.5_Paraxial Mesoderm_500_K3 | |
| CoexpressionAtlas | FacebaseRNAseq_e9.5_Maxillary Arch_top-relative-expression-ranked_1000 | SHANK1 COL24A1 COL7A1 FBLN2 KLF1 CACNA1H CACNA1G REPS2 ZNHIT2 RAX ACSS3 COL1A1 COL1A2 | 6.19e-05 | 967 | 80 | 13 | Facebase_RNAseq_e9.5_Maxillary Arch_1000 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Olfactory Pit_top-relative-expression-ranked_1000_k-means-cluster#5 | 8.21e-05 | 276 | 80 | 7 | Facebase_RNAseq_e10.5_Olfactory Pit_1000_K5 | |
| CoexpressionAtlas | FacebaseRNAseq_e8.5_Paraxial Mesoderm_top-relative-expression-ranked_500 | SHANK1 COL24A1 COL7A1 FBLN2 CACNA1G REPS2 ACSS3 COL1A1 COL1A2 | 9.21e-05 | 489 | 80 | 9 | Facebase_RNAseq_e8.5_Paraxial Mesoderm_500 |
| CoexpressionAtlas | FacebaseRNAseq_e9.5_Facial Mesenchyne_top-relative-expression-ranked_1000_k-means-cluster#3 | 9.91e-05 | 384 | 80 | 8 | Facebase_RNAseq_e9.5_Facial Mesenchyne_1000_K3 | |
| CoexpressionAtlas | FacebaseRNAseq_e8.5_Non-Floor Plate Neural Epithelium_top-relative-expression-ranked_2500_k-means-cluster#1 | COL3A1 COL5A2 COL24A1 FBLN2 COL17A1 KLF1 CACNA1G REPS2 SH3RF3 ACSS3 COL1A1 COL1A2 | 1.05e-04 | 878 | 80 | 12 | Facebase_RNAseq_e8.5_Non-Floor Plate Neural Epithelium_2500_K1 |
| CoexpressionAtlas | BM Top 100 - cervix | 1.13e-04 | 66 | 80 | 4 | BM Top 100 - cervix | |
| CoexpressionAtlas | FacebaseRNAseq_e8.5_Non-Floor Plate Neural Epithelium_top-relative-expression-ranked_1000_k-means-cluster#4 | 1.32e-04 | 298 | 80 | 7 | Facebase_RNAseq_e8.5_Non-Floor Plate Neural Epithelium_1000_K4 | |
| CoexpressionAtlas | facebase_RNAseq_e14.5_palate_poster_proximal_ERK2_WT_2500_K2 | SHANK1 COL5A2 COL7A1 FBLN2 SZT2 HECTD3 GLI2 PI4KB CACNA1G VARS2 TSC22D2 MN1 PRRC2A COL1A2 | 1.53e-04 | 1208 | 80 | 14 | facebase_RNAseq_e14.5_palate_poster_proximal_ERK2_WT_2500_K2 |
| CoexpressionAtlas | dev gonad_e12.5_M_InterstitLeydig_MafB_k-means-cluster#1_top-relative-expression-ranked_1000 | 1.69e-04 | 310 | 80 | 7 | gudmap_dev gonad_e12.5_M_InterstitLeydig_MafB_k1_1000 | |
| CoexpressionAtlas | FacebaseRNAseq_ratio_e9.5_MaxillaryArch_vs_Mandibular_top-relative-expression-ranked_1000 | SHANK1 COL24A1 COL7A1 ABCA2 FBLN2 CACNA1H CACNA1G REPS2 RAX ACSS3 COL1A1 COL1A2 | 2.69e-04 | 972 | 80 | 12 | Facebase_RNAseq_ratio_e9.5_MaxillaryArch_vs_Mandibular_1000 |
| CoexpressionAtlas | FacebaseRNAseq_e8.5_Non-Floor Plate Neural Epithelium_top-relative-expression-ranked_1000 | SHANK1 COL24A1 COL7A1 ABCA2 FBLN2 CACNA1H CACNA1G REPS2 RAX ACSS3 COL1A1 COL1A2 | 2.80e-04 | 976 | 80 | 12 | Facebase_RNAseq_e8.5_Non-Floor Plate Neural Epithelium_1000 |
| CoexpressionAtlas | FacebaseRNAseq_e9.5_Olfactory Placode_top-relative-expression-ranked_1000_k-means-cluster#5 | 3.20e-04 | 244 | 80 | 6 | Facebase_RNAseq_e9.5_Olfactory Placode_1000_K5 | |
| CoexpressionAtlas | FacebaseRNAseq_e9.5_Maxillary Arch_top-relative-expression-ranked_2500_k-means-cluster#1 | COL3A1 COL5A2 COL24A1 FBLN2 COL17A1 CACNA1G ZNHIT2 COL1A1 COL1A2 | 3.68e-04 | 589 | 80 | 9 | Facebase_RNAseq_e9.5_Maxillary Arch_2500_K1 |
| CoexpressionAtlas | FacebaseRNAseq_ratio_e10.5_MandibularArch_vs_MaxillaryArch_top-relative-expression-ranked_2500_k-means-cluster#4 | COL3A1 COL5A2 COL24A1 FBLN2 COL17A1 CACNA1G ACSS3 COL1A1 COL1A2 | 3.77e-04 | 591 | 80 | 9 | Facebase_RNAseq_ratio_e10.5_MandibularArch_vs_MaxillaryArch_2500_K4 |
| CoexpressionAtlas | dev gonad_e13.5_F_VascAssocMesenchStromOvary_Sma_k-means-cluster#4_top-relative-expression-ranked_1000 | 4.35e-04 | 168 | 80 | 5 | gudmap_dev gonad_e13.5_F_VascAssocMesenchStromOvary_Sma_k4_1000 | |
| CoexpressionAtlas | FacebaseRNAseq_ratio_e9.5_MaxillaryArch_vs_Mandibular_top-relative-expression-ranked_500_k-means-cluster#5 | 4.84e-04 | 172 | 80 | 5 | Facebase_RNAseq_ratio_e9.5_MaxillaryArch_vs_Mandibular_500_K5 | |
| CoexpressionAtlas | FacebaseRNAseq_ratio_e9.5_MaxillaryArch_vs_Mandibular_top-relative-expression-ranked_1000_k-means-cluster#1 | 4.96e-04 | 265 | 80 | 6 | Facebase_RNAseq_ratio_e9.5_MaxillaryArch_vs_Mandibular_1000_K1 | |
| CoexpressionAtlas | Progenitor-Cell-Biology-Consortium_EmbryoidBody_from_inducedPluripotentialStemCells_derived from_from_fibroblast_top-relative-expression-ranked_500 | 5.64e-04 | 497 | 80 | 8 | PCBC_EB_fibroblast_500 | |
| CoexpressionAtlas | Mesoderm Day 5-reprogram_OSKM-L_vs_Mesoderm Day 5-reprogram_NA-Confounder_removed-fold2.0_adjp0.05 | 6.74e-04 | 281 | 80 | 6 | PCBC_ratio_MESO-5_from-OSKM-L_vs_MESO-5_from-ESC_cfr-2X-p05 | |
| CoexpressionAtlas | Mesoderm Day 5-method_mRNA_vs_Mesoderm Day 5-method_NA-Confounder_removed-fold2.0_adjp0.05 | 6.74e-04 | 281 | 80 | 6 | PCBC_ratio_MESO-5_from-mRNA_vs_MESO-5_from-ESC_cfr-2X-p05 | |
| CoexpressionAtlas | dev gonad_e12.5_F_VasAssMesen_MafB_k-means-cluster#3_top-relative-expression-ranked_1000 | 7.18e-04 | 107 | 80 | 4 | gudmap_dev gonad_e12.5_F_VasAssMesen_MafB_k3_1000 | |
| CoexpressionAtlas | MESO-30 amniotic fluid MSC_vs_MESO-30 blastocyst-Confounder_removed-fold2.0_adjp0.05 | COL7A1 ABCA2 ARID1B COL17A1 GLI2 DENND4B CACNA1H ZBTB12 ZFPM1 ZNF385A MN1 RAX DMAP1 | 7.28e-04 | 1245 | 80 | 13 | PCBC_ratio_MESO-30 amniotic fluid MSC_vs_MESO-30 blastocyst_cfr-2X-p05 |
| CoexpressionAtlas | AravindRamakr_EmbryoidBody-LF_top-relative-expression-ranked_2500_k-means-cluster#2 | COL3A1 MAP6 BARHL1 ELAVL3 CACNA1G GRIN2D RAX PDE11A COL1A1 COL1A2 FOXC2 | 8.50e-04 | 951 | 80 | 11 | Arv_EB-LF_2500_K2 |
| ToppCell | Children_(3_yrs)-Mesenchymal-myofibroblast_cell-D046|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.03e-09 | 173 | 81 | 8 | 1f16d47f5548e257e4b17f8070c5619780a9c5fd | |
| ToppCell | droplet-Lung-1m-Mesenchymal-fibroblast-adventitial_fibroblast-adventitial_fibroblast_l17|1m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.90e-09 | 187 | 81 | 8 | ed7ab4cf4629d96dad5c74d536fc428d0a8d4eb9 | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-matrix_fibroblast_2_cell-D062|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 2.75e-09 | 196 | 81 | 8 | 525d6c8a277364e624e7cc586275f8a891436b57 | |
| ToppCell | Bronchial-NucSeq-Stromal-Fibroblastic-Fibro_adventitial|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 3.23e-09 | 200 | 81 | 8 | ad3fdcef895400f929f2ae12ff9bd85fd46adb3a | |
| ToppCell | Substantia_nigra-Endothelial-ENDOTHELIAL_TIP|Substantia_nigra / BrainAtlas - Mouse McCarroll V32 | 1.68e-08 | 159 | 81 | 7 | cb2470b288c13e454a2a80115b0d5613b3f718e6 | |
| ToppCell | Hippocampus-Endothelial-ENDOTHELIAL_TIP-Dcn_1|Hippocampus / BrainAtlas - Mouse McCarroll V32 | 1.68e-08 | 159 | 81 | 7 | 92049a8d8fc9997d8d0d76500c72596a9b2394e0 | |
| ToppCell | E16.5-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF2-AF2_mature|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.17e-08 | 165 | 81 | 7 | 4e13fccd32029e2879e85f8966e582a46c09e4aa | |
| ToppCell | facs-Limb_Muscle-forelimb_and_hindlimb-18m-Mesenchymal-mesenchymal_stem_cell|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.17e-08 | 165 | 81 | 7 | f80665b75d43f1bf6919d59fc762e7e0bac653f2 | |
| ToppCell | E16.5-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF2|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.36e-08 | 167 | 81 | 7 | fe3338f99f94c0dac37e3d649dfdce82e4a56022 | |
| ToppCell | 5'-Adult-LargeIntestine-Mesenchymal-fibroblastic-Stromal_1_(ADAMDEC1+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.56e-08 | 169 | 81 | 7 | c0824a93674e2bff0f09b2d2fab5bab016a2e379 | |
| ToppCell | 5'-Adult-SmallIntestine-Mesenchymal-fibroblastic-Stromal_1_(ADAMDEC1+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.95e-08 | 180 | 81 | 7 | f2f6e83127a4a415e65c76a35efa8175fbd5b5d9 | |
| ToppCell | Hippocampus-Endothelial-ENDOTHELIAL_TIP-Dcn_1-Dcn_1_1-Endothelial_Tip.Dcn.Mgp_(Mgp)-|Hippocampus / BrainAtlas - Mouse McCarroll V32 | 4.41e-08 | 107 | 81 | 6 | 13af691c8533418d2800a8eca61155896b559948 | |
| ToppCell | Hippocampus-Endothelial-ENDOTHELIAL_TIP-Dcn_1-Dcn_1_1-Endothelial_Tip.Dcn.Mgp_(Mgp)|Hippocampus / BrainAtlas - Mouse McCarroll V32 | 4.41e-08 | 107 | 81 | 6 | a5a34bb9706527799ddb494d4f1bfc634c29e8a9 | |
| ToppCell | droplet-Lung-21m-Mesenchymal-fibroblast-adventitial_fibroblast-adventitial_fibroblast_l17|21m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 4.77e-08 | 185 | 81 | 7 | 1b990e3089772be2b38c6d7ea0d1bf22461ae3ea | |
| ToppCell | E17.5-Mesenchymal-mesenchymal_fibroblast-mesenchymal_alveolar_niche_cell|E17.5 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 4.77e-08 | 185 | 81 | 7 | c85bba1210f1d389add3e40be9b96abac40cf8c1 | |
| ToppCell | droplet-Mammary_Gland-nan-21m-Mesenchymal-nan|Mammary_Gland / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.95e-08 | 186 | 81 | 7 | cc94e0c5d1665d2ea2bb871ad79d8e1ec2249fb5 | |
| ToppCell | droplet-Pancreas-Exocrine-18m-Mesenchymal-pancreatic_stellate_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.13e-08 | 187 | 81 | 7 | 4e553721fa5598cb211f44e3226280b7e6885484 | |
| ToppCell | droplet-Pancreas-Exocrine-18m-Mesenchymal|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.13e-08 | 187 | 81 | 7 | d36e7fc6125e7a4310499365022d38f34b757a73 | |
| ToppCell | droplet-Pancreas-Exocrine-18m-Mesenchymal-pancreatic_stellate_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.13e-08 | 187 | 81 | 7 | 827eae63fabf6892a82ce7779b5f395958d3d628 | |
| ToppCell | Control-Fibroblasts-Adventitial_FB|Control / group, cell type (main and fine annotations) | 5.33e-08 | 188 | 81 | 7 | 706a26c372add839d947749f0521a0e1f5c9b0ec | |
| ToppCell | 5'-Adult-LargeIntestine-Mesenchymal-fibroblastic-Stromal_2_(NPY+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 5.33e-08 | 188 | 81 | 7 | 997dcfc4f08738ab398d8abc15e4fd2fc6619862 | |
| ToppCell | Mesenchymal-myofibroblast_cell|World / Lineage, Cell type, age group and donor | 5.52e-08 | 189 | 81 | 7 | 44e37f88137bb249933eb615235b2cf2ae7f3925 | |
| ToppCell | Adult-Mesenchymal-matrix_fibroblast_2_cell-D175|Adult / Lineage, Cell type, age group and donor | 5.73e-08 | 190 | 81 | 7 | 7dcca3469f3a3b70db0420cb94f7765f39492f06 | |
| ToppCell | 3'-Adult-LargeIntestine-Mesenchymal-myocytic-myofibroblast|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 5.73e-08 | 190 | 81 | 7 | 591310e615700321a010a4b90405cbbbbdb3aade | |
| ToppCell | E18.5-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF2-AF2_mature|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 5.93e-08 | 191 | 81 | 7 | 75d2197076a9dfc868e8baf95bd4c5e44f438e3e | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Mesenchymal-Myocytic_interstitial_cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 5.93e-08 | 191 | 81 | 7 | 04c4d454b57e29a8d1dcdeb4678ce71bdc29b77b | |
| ToppCell | droplet-Lung-30m-Mesenchymal-fibroblast-adventitial_fibroblast-adventitial_fibroblast_l1|30m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 5.93e-08 | 191 | 81 | 7 | 24dc77ee8de01b42559f92721655f4281b114e17 | |
| ToppCell | nucseq-Mesenchymal-Myocytic-Myocytic_2-SCMF|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 6.15e-08 | 192 | 81 | 7 | 67e845e513e76e820f55e2f0d15eb16f2944d05c | |
| ToppCell | droplet-Lung-18m-Mesenchymal-fibroblast-adventitial_fibroblast-adventitial_fibroblast_l49|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 6.15e-08 | 192 | 81 | 7 | 1b228f0929b505de82a39bf64c837887b0e56701 | |
| ToppCell | Children_(3_yrs)-Mesenchymal-matrix_fibroblast_2_cell-D046|Children_(3_yrs) / Lineage, Cell type, age group and donor | 6.15e-08 | 192 | 81 | 7 | e0f4e4470a71bfa81d9dcd8594e5f82aafc24f81 | |
| ToppCell | Adult-Mesenchymal-matrix_fibroblast_2_cell|Adult / Lineage, Cell type, age group and donor | 6.15e-08 | 192 | 81 | 7 | d21f0f577156f17c899b08871046a26b88aea011 | |
| ToppCell | Mesenchymal-matrix_fibroblast_2_cell|World / Lineage, Cell type, age group and donor | 6.15e-08 | 192 | 81 | 7 | a769158c49d2b208c4224d85e7ae68c85cc372ed | |
| ToppCell | PCW_07-8.5-Mesenchymal-Mesenchymal_fibroblastic-mes_adventitial_fibro_(10)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 6.37e-08 | 193 | 81 | 7 | cd45118ced91b10baed3b1068d4673ec99824b86 | |
| ToppCell | Children_(3_yrs)-Mesenchymal-matrix_fibroblast_2_cell|Children_(3_yrs) / Lineage, Cell type, age group and donor | 6.37e-08 | 193 | 81 | 7 | 9ab47b360bee1d4f1092c2269e58acebe9584021 | |
| ToppCell | facs-Diaphragm-Limb_Muscle-3m-Mesenchymal-mesenchymal_stem_cell|Diaphragm / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.37e-08 | 193 | 81 | 7 | 160691b671710be10220803d788c2c961c236af1 | |
| ToppCell | droplet-Lung-18m-Mesenchymal-fibroblast-adventitial_fibroblast-adventitial_fibroblast_l1|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 6.60e-08 | 194 | 81 | 7 | 5594f7437448cb4b37d2d100f44d30c4a367df26 | |
| ToppCell | facs-Kidney-nan-18m-Mesenchymal-mesangial_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.60e-08 | 194 | 81 | 7 | bbc625b4cc53bb7d6254fde287258e51f9171572 | |
| ToppCell | Control-Fibroblasts-Intermediate_pathological_FB|Control / group, cell type (main and fine annotations) | 6.60e-08 | 194 | 81 | 7 | 03a269f75a481ea54aea8e6444605db8d6df493d | |
| ToppCell | facs-Kidney-nan-18m-Mesenchymal|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.60e-08 | 194 | 81 | 7 | fcd5e9238d299c41f0bf9693b56cd8c900d2112b | |
| ToppCell | COVID-19-Heart-Fib_2|Heart / Disease (COVID-19 only), tissue and cell type | 6.60e-08 | 194 | 81 | 7 | d91c9f2ec47319051fc398320693fddbe8bbd4d6 | |
| ToppCell | facs-Kidney-nan-18m-Mesenchymal-mesangial_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.60e-08 | 194 | 81 | 7 | 6afc21c5fec30ab8e373e3e46ab7866204c805b6 | |
| ToppCell | TCGA-Head_and_Esophagus-Primary_Tumor-Head_and_Neck_Carcinoma-Squamous_Cell_Carcinoma-8|TCGA-Head_and_Esophagus / Sample_Type by Project: Shred V9 | 6.60e-08 | 194 | 81 | 7 | 55b97095a7a17a312c616703d291738a0f806339 | |
| ToppCell | facs-Heart-LA-3m-Mesenchymal|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.84e-08 | 195 | 81 | 7 | 79a6e8e6de040ff07539e8901fc407363a50e355 | |
| ToppCell | facs-Heart-LA|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.08e-08 | 196 | 81 | 7 | 8a84aeb1a565dd3e2a690fcaf1ab804f5e253545 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 7.08e-08 | 196 | 81 | 7 | b8759e6231e0254797d6c30930407b79440c57bb | |
| ToppCell | facs-Heart-LA-3m-Mesenchymal-fibroblast_of_cardiac_tissue|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.08e-08 | 196 | 81 | 7 | ad1838dabd043cb140260843e3527d8c7d58850e | |
| ToppCell | facs-Heart-LA-3m-Mesenchymal-fibroblast_of_cardiac_tissue|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.08e-08 | 196 | 81 | 7 | cbc15c0769016fe9972445169029bd8d14a7e6ef | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Mesenchymal-Fibroblast-Collagen+matrisome-high_fibroblast-|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 7.33e-08 | 197 | 81 | 7 | 85a8f1d18e0dd1d31341f5131eecd217553bf042 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Mesenchymal-Fibroblast-Collagen+matrisome-high_fibroblast|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 7.33e-08 | 197 | 81 | 7 | e8e3ba791dfaa0fab35e0329a5e34376f9ee6143 | |
| ToppCell | PCW_13-14-Mesenchymal|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 7.33e-08 | 197 | 81 | 7 | 73a2085d2682d636726a5432d572ae2a3fbe1c3f | |
| ToppCell | facs-Heart-LA-3m|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.33e-08 | 197 | 81 | 7 | 2a91738cb6d7588869dd00deeea0cbbc2d6aa34d | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Mesenchymal|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 7.33e-08 | 197 | 81 | 7 | 9b480f9c799a244bfee64487abd8a1bf07c9a3a2 | |
| ToppCell | (02)_MMP9/10+|World / shred by cell type by condition | 7.85e-08 | 199 | 81 | 7 | 3f78eddeaa67d3b767aa38de765632166b09a4f0 | |
| ToppCell | Bronchial-10x5prime-Stromal-Fibroblastic-Fibro_myofibroblast|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 7.85e-08 | 199 | 81 | 7 | 21335475bbfbad8a6943b8076a6c1c67f3eec5d3 | |
| ToppCell | (2)_Fibroblasts-(24)_Fibro-5|World / Cell class and subclass of bone marrow stroma cells in homeostatis | 7.85e-08 | 199 | 81 | 7 | 6c0354f57883330c685a8d9d5d3014ace7eca584 | |
| ToppCell | Parenchymal-10x5prime-Stromal-Fibroblastic-Fibro_myofibroblast|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 8.13e-08 | 200 | 81 | 7 | 54806080b5e97859ee6a4a9b4f19e22021c218f5 | |
| ToppCell | Parenchymal-NucSeq-Stromal-Fibroblastic-Fibro_adventitial|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 8.13e-08 | 200 | 81 | 7 | 74e74123ea7bf38d337a3a0248a6a51437c6ab42 | |
| ToppCell | Bronchial-NucSeq-Stromal-Fibroblastic-Fibro_peribronchial|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 8.13e-08 | 200 | 81 | 7 | fb53be20392a8309a7393774c774a1b1aec6e676 | |
| ToppCell | Tracheal-NucSeq-Stromal-Fibroblastic-Fibro_peribronchial|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 8.13e-08 | 200 | 81 | 7 | 58b38f9a484ee94191091a0659ed62ebed2d4a14 | |
| ToppCell | Hippocampus-Endothelial-ENDOTHELIAL_TIP-Dcn_1-Dcn_1_1|Hippocampus / BrainAtlas - Mouse McCarroll V32 | 1.68e-07 | 134 | 81 | 6 | b959899c89d3a0363a3cd2309155280e0fe5ba88 | |
| ToppCell | Thalamus-Endothelial-ENDOTHELIAL_TIP-Dcn_1|Thalamus / BrainAtlas - Mouse McCarroll V32 | 3.69e-07 | 153 | 81 | 6 | e9c6fb5c41adb6595c66c3a917fe455348279e54 | |
| ToppCell | Thalamus-Endothelial-ENDOTHELIAL_TIP-Dcn_1-Dcn_1_1|Thalamus / BrainAtlas - Mouse McCarroll V32 | 3.69e-07 | 153 | 81 | 6 | b8b5ff7d2feea3e3a352fb5530e49f639fe1ff88 | |
| ToppCell | Thalamus-Endothelial-ENDOTHELIAL_TIP|Thalamus / BrainAtlas - Mouse McCarroll V32 | 3.69e-07 | 153 | 81 | 6 | 2513edfae62a44e51d3556675a096723194c966c | |
| ToppCell | Children_(3_yrs)-Mesenchymal-chondrocyte|Children_(3_yrs) / Lineage, Cell type, age group and donor | 4.29e-07 | 157 | 81 | 6 | f147e24f2ece82e1c54750868954d09b3c461804 | |
| ToppCell | Children_(3_yrs)-Mesenchymal-chondrocyte-D046|Children_(3_yrs) / Lineage, Cell type, age group and donor | 4.45e-07 | 158 | 81 | 6 | e5636c0b608d68bd426a2b446ac508e4512e86a4 | |
| ToppCell | frontal_cortex-Non-neuronal-leptomeningeal_cell-VLMC-VLMC_Spp1_Col15a1|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 4.62e-07 | 159 | 81 | 6 | 34c90711c5857cf6ada7b3acff99f1d48c7caf29 | |
| ToppCell | TCGA-Cervix-Primary_Tumor-Cervical_Carcinoma-Keratinizing_Cervical_Squamous_Cell_Carcinoma|TCGA-Cervix / Sample_Type by Project: Shred V9 | 5.54e-07 | 164 | 81 | 6 | de1646dbcf2a10b48e021acf7dc63e803e6a47ce | |
| ToppCell | Children_(3_yrs)-Mesenchymal-airway_smooth_muscle_cell-D046|Children_(3_yrs) / Lineage, Cell type, age group and donor | 5.54e-07 | 164 | 81 | 6 | e3983f655cdba308fb192182829f17bef99ce0ba | |
| ToppCell | normal_Lung-Fibroblasts-Myofibroblasts|Fibroblasts / Location, Cell class and cell subclass | 5.54e-07 | 164 | 81 | 6 | 9b4a6007abae992db871d9f6f731d5af724de30d | |
| ToppCell | 356C-Fibroblasts-Fibroblast-C_(Myofibroblast)-|356C / Donor, Lineage, Cell class and subclass (all cells) | 8.65e-07 | 177 | 81 | 6 | cdfd2f0ee2f692271b1525e414b0f645cdadb1f6 | |
| ToppCell | 3'-GW_trimst-1.5-LargeIntestine-Mesenchymal-fibroblastic-Stromal_3_(C7+)|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 8.65e-07 | 177 | 81 | 6 | 7af1a19692f7fe8f691178a4e57d62bc379e3d56 | |
| ToppCell | 356C-Fibroblasts-Fibroblast-C_(Myofibroblast)|356C / Donor, Lineage, Cell class and subclass (all cells) | 8.65e-07 | 177 | 81 | 6 | db222faaecbe5600da39277243c4e7e764eb63c9 | |
| ToppCell | 356C-Fibroblasts-Fibroblast-E-|356C / Donor, Lineage, Cell class and subclass (all cells) | 8.94e-07 | 178 | 81 | 6 | a493a277d175e5e153410a745b26ebe2e0839ea0 | |
| ToppCell | E16.5-Mesenchymal-Mesenchymal_structural-Fibroblastic-Mesothelial-Mesothelial_mature|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 8.94e-07 | 178 | 81 | 6 | a107dd98a07086ed0429116095ecda60c9dbef1e | |
| ToppCell | 356C-Fibroblasts-Fibroblast-E|356C / Donor, Lineage, Cell class and subclass (all cells) | 8.94e-07 | 178 | 81 | 6 | 371218babddfd3d8a7bb82a46ce65327ee3fcf12 | |
| ToppCell | renal_papilla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 9.54e-07 | 180 | 81 | 6 | 280ff5c8f292be1b88120db5ff1788b750644856 | |
| ToppCell | renal_papilla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast-|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 9.54e-07 | 180 | 81 | 6 | fdbd7c22044d9328a1e06e2f9a4451529d1df767 | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-Degenerative_Fibroblast|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 9.86e-07 | 181 | 81 | 6 | 6d1f1ad35778a2a227f966f11f6edd8e89452576 | |
| ToppCell | PND14-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF2|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 9.86e-07 | 181 | 81 | 6 | 3462aa1c08fbaf613b6278ab2c7a5a0940bf537d | |
| ToppCell | facs-Brain_Non-Myeloid-Cerebellum_-18m-Epithelial-neuroepithelial_cell|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.86e-07 | 181 | 81 | 6 | c26d3cbbc592299786d79d1b15fc6bead2aafb9a | |
| ToppCell | -Myositis-ILD_01|World / lung cells shred on cell class, cell subclass, sample id | 9.86e-07 | 181 | 81 | 6 | ef579e958f334da0f9415aa7e3d5c02c807954a6 | |
| ToppCell | PND14-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF2-AF2_mature|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 9.86e-07 | 181 | 81 | 6 | 6730e249cac55ae892cc567d9211615882f3dab4 | |
| ToppCell | PND01-03-samps-Mesenchymal-Myofibroblast|PND01-03-samps / Age Group, Lineage, Cell class and subclass | 1.02e-06 | 182 | 81 | 6 | 812dac35b9aa05be48258082e007f6c00e7b4dd8 | |
| ToppCell | Pericytes-Cryobiopsy_01|World / lung cells shred on cell class, cell subclass, sample id | 1.02e-06 | 182 | 81 | 6 | 46c213597445b1f4f09dc367f27702d24b201daf | |
| ToppCell | 3'-Broncho-tracheal-Mesenchymal-Fibroblastic-fibroblastic_type_1-Adventitial_fibroblasts-Adventitial_fibroblasts_L.2.1.2.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.02e-06 | 182 | 81 | 6 | d179b5deb07c20d49eb6c58d5a65904f8921de3a | |
| ToppCell | 5'-Airway_Nasal-Epithelial-Airway_epithelium-respiratory_basal_cell-Suprabasal-Suprabasal_L.0.0.2.2|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.05e-06 | 183 | 81 | 6 | bbf27d2f4369031fadacacd6c432c06b1ec5abdb | |
| ToppCell | droplet-Trachea-3m-Mesenchymal-myofibroblast-tracheobronchial_smooth_muscle_cell-smooth_muscle_cell_of_trachea_l1-41|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.05e-06 | 183 | 81 | 6 | 07ca2786e62eca9feecf5e54a11864a960f7641a | |
| ToppCell | normal_Lung-Fibroblasts-Myofibroblasts|normal_Lung / Location, Cell class and cell subclass | 1.08e-06 | 184 | 81 | 6 | 0b336489c10e8c3c957795dd845454f03404382b | |
| ToppCell | Adult-Mesenchymal-matrix_fibroblast_2_cell-D122|Adult / Lineage, Cell type, age group and donor | 1.08e-06 | 184 | 81 | 6 | 2b7e6f91e11c228f0521e099886867d9e998e78d | |
| ToppCell | 390C-Fibroblasts-Fibroblast-F|390C / Donor, Lineage, Cell class and subclass (all cells) | 1.12e-06 | 185 | 81 | 6 | 2c1f14f77faeee2acb388d997c5a27a7fef79be1 | |
| ToppCell | Adult-Mesenchymal-matrix_fibroblast_2_cell-D231|Adult / Lineage, Cell type, age group and donor | 1.12e-06 | 185 | 81 | 6 | fb6bd7e849ecf4ed9cd9c4e2a946a2d12d62f804 | |
| ToppCell | 390C-Fibroblasts-Fibroblast-F-|390C / Donor, Lineage, Cell class and subclass (all cells) | 1.12e-06 | 185 | 81 | 6 | 37db8e0b1f59274227f6fc2362167eb44bd080ef | |
| ToppCell | 343B-Fibroblasts-Fibroblast-E-|343B / Donor, Lineage, Cell class and subclass (all cells) | 1.16e-06 | 186 | 81 | 6 | 1bac7825c2fe3e6cdff65026b09b9ccaa40fa27f | |
| ToppCell | 343B-Fibroblasts-Fibroblast-E|343B / Donor, Lineage, Cell class and subclass (all cells) | 1.16e-06 | 186 | 81 | 6 | 59db239f1864a5d4f1570c93219dbd7ac5b6db35 | |
| ToppCell | facs-Limb_Muscle-Muscle_forelimb_and_hindlimb-18m-Mesenchymal-mesenchymal_stem_cell|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.16e-06 | 186 | 81 | 6 | a7ab70b049742dfe7ee30557031bfac6412edf52 | |
| ToppCell | Control-Fibroblasts-Pathological_FB|Control / group, cell type (main and fine annotations) | 1.19e-06 | 187 | 81 | 6 | b7280b8baa0fba9c2b4bff660c240ed96f6ff9b7 | |
| ToppCell | LA-01._Fibroblast_I|World / Chamber and Cluster_Paper | 1.19e-06 | 187 | 81 | 6 | 4ea486991f66c29728d127171a07b81404ec0b78 | |
| ToppCell | PCW_07-8.5-Mesenchymal-Mesenchymal_fibroblastic-mes_immature3_(17)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 1.19e-06 | 187 | 81 | 6 | a9316e2818217ec5feae9cf8816f7249803caee6 | |
| ToppCell | 3'-Adult-LargeIntestine-Mesenchymal-fibroblastic-Stromal_1_(ADAMDEC1+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.19e-06 | 187 | 81 | 6 | 6f47a80e612b320f571210483e62ff5db2a8ea43 | |
| ToppCell | droplet-Lung-3m-Mesenchymal-fibroblast-alveolar_fibroblast-alveolar_fibroblast_l1|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.23e-06 | 188 | 81 | 6 | b382d18fb09fb2869f3c151efa71540a7f5ed229 | |
| Computational | Neighborhood of CDH11 | 3.79e-06 | 25 | 47 | 4 | GNF2_CDH11 | |
| Computational | Neighborhood of PTX3 | 1.71e-05 | 36 | 47 | 4 | GNF2_PTX3 | |
| Computational | Genes upregulated in subsets of cells of a given type within various tumors | 6.38e-05 | 50 | 47 | 4 | GAVISH_3CA_METAPROGRAM_FIBROBLASTS_CAF_1 | |
| Computational | ECM and collagens. | 4.12e-04 | 225 | 47 | 6 | MODULE_47 | |
| Drug | GK-101 | 3.89e-11 | 36 | 80 | 7 | CID000161853 | |
| Drug | Madecassol | 2.42e-10 | 46 | 80 | 7 | CID000108062 | |
| Drug | d-indobufen | 4.47e-10 | 50 | 80 | 7 | CID000044562 | |
| Drug | ridogrel | 5.96e-10 | 52 | 80 | 7 | CID005362391 | |
| Drug | NSC49633 | 6.84e-10 | 53 | 80 | 7 | CID000023340 | |
| Drug | AC1LAKND | 2.13e-09 | 62 | 80 | 7 | CID000470146 | |
| Drug | BAPN | 5.61e-09 | 71 | 80 | 7 | CID000001647 | |
| Drug | malotilate | 5.61e-09 | 71 | 80 | 7 | CID000004006 | |
| Drug | AC1NMZ1B | 8.28e-09 | 75 | 80 | 7 | CID005034185 | |
| Drug | strontium ranelate | 9.98e-09 | 77 | 80 | 7 | CID006918182 | |
| Drug | Selara | 1.37e-08 | 125 | 80 | 8 | CID000150310 | |
| Drug | halofuginone lactate | 2.00e-08 | 85 | 80 | 7 | CID000062891 | |
| Drug | 4-hydroxyproline | 3.23e-08 | 91 | 80 | 7 | CID000000825 | |
| Drug | ticlopidine | 7.64e-08 | 103 | 80 | 7 | CID000005472 | |
| Drug | hydroxylysine | 1.13e-07 | 109 | 80 | 7 | CID000001029 | |
| Drug | AC1Q6PCP | COL3A1 COL4A6 COL24A1 COL7A1 COL17A1 CACNA1H CACNA1G COL1A1 COL1A2 | 1.17e-07 | 230 | 80 | 9 | CID000005267 |
| Drug | AC1L1C2F | 1.20e-07 | 110 | 80 | 7 | CID000001711 | |
| Drug | PPACK | 1.45e-07 | 113 | 80 | 7 | CID003036757 | |
| Drug | AC1L9732 | 1.54e-07 | 114 | 80 | 7 | CID000439300 | |
| Drug | Tranilast sodium | 1.63e-07 | 115 | 80 | 7 | CID000005527 | |
| Drug | Collagenase | 1.67e-07 | 4 | 80 | 3 | DB00048 | |
| Drug | DMSe | 4.19e-07 | 132 | 80 | 7 | CID000020796 | |
| Drug | pirfenidone | 5.67e-07 | 138 | 80 | 7 | CID000040632 | |
| Drug | DL-penicillamine | 5.95e-07 | 139 | 80 | 7 | CID000004727 | |
| Drug | PCR 4099 | 5.95e-07 | 139 | 80 | 7 | CID000002806 | |
| Drug | candesartan cilexetil | 7.92e-07 | 145 | 80 | 7 | CID000002540 | |
| Drug | 2-phenyl-4-(3-pyridin-2-yl-1H-pyrazol-4-yl)pyridine | 8.29e-07 | 6 | 80 | 3 | ctd:C502971 | |
| Drug | L-lysyl-L-lysyl-L-lysine | 1.67e-06 | 162 | 80 | 7 | CID000072363 | |
| Drug | khellin | 2.39e-06 | 171 | 80 | 7 | CID000003828 | |
| Drug | AC1L1DD6 | 3.23e-06 | 179 | 80 | 7 | CID000002299 | |
| Drug | 12(S)-hydroxyeicosatetraenoic acid | 4.63e-06 | 189 | 80 | 7 | CID000001413 | |
| Drug | foscarnet | 4.79e-06 | 190 | 80 | 7 | CID000003414 | |
| Drug | Betonicine [515-25-3]; Up 200; 25.2uM; PC3; HT_HG-U133A | 5.88e-06 | 196 | 80 | 7 | 3745_UP | |
| Drug | AC1L1KMJ | COL3A1 COL4A6 COL24A1 COL7A1 COL17A1 PI4KB MARCO TLX2 COL1A1 COL1A2 | 6.46e-06 | 476 | 80 | 10 | CID000030956 |
| Drug | Isoetharine mesylate salt [7279-75-6]; Down 200; 12uM; MCF7; HT_HG-U133A | 6.49e-06 | 199 | 80 | 7 | 7170_DN | |
| Drug | 5'-methylthioadenosine | 1.22e-05 | 2 | 80 | 2 | ctd:C008500 | |
| Drug | fullerene C60 | JUNB NCOA6 COL7A1 DRD5 MAP6 HS6ST1 INPPL1 SYN1 CACNA1G ZFPM1 GRIN2D SH3RF3 PRRC2A CSTF2T TLX2 FOSL1 FOXC2 | 1.42e-05 | 1498 | 80 | 17 | ctd:C069837 |
| Drug | ascorbate-2-phosphate | 1.84e-05 | 15 | 80 | 3 | ctd:C011669 | |
| Drug | prostacyclin sodium salt | 2.84e-05 | 250 | 80 | 7 | CID000000159 | |
| Drug | 1,3-dioxoisoindoline-5-carboxamide | 3.65e-05 | 3 | 80 | 2 | CID010679219 | |
| Drug | hyaluronan | 3.92e-05 | 263 | 80 | 7 | CID000024759 | |
| Drug | losartan | 5.48e-05 | 378 | 80 | 8 | CID000003961 | |
| Drug | silibinin | 6.51e-05 | 285 | 80 | 7 | CID000005213 | |
| Drug | Aztreonam [78110-38-0]; Down 200; 9.2uM; MCF7; HT_HG-U133A | 6.86e-05 | 197 | 80 | 6 | 2282_DN | |
| Drug | Ketoconazole [65277-42-1]; Up 200; 7.6uM; MCF7; HT_HG-U133A | 6.86e-05 | 197 | 80 | 6 | 5685_UP | |
| Drug | 2-propylpentanoic acid; Up 200; 50uM; PC3; HT_HG-U133A | 7.06e-05 | 198 | 80 | 6 | 4446_UP | |
| Drug | Benzydamine hydrochloride [132-69-4]; Down 200; 11.6uM; MCF7; HT_HG-U133A | 7.06e-05 | 198 | 80 | 6 | 7169_DN | |
| Drug | Terazosin hydrochloride [63590-64-7]; Up 200; 9.4uM; MCF7; HT_HG-U133A | 7.26e-05 | 199 | 80 | 6 | 6092_UP | |
| Drug | Dactinomycin | 7.26e-05 | 290 | 80 | 7 | ctd:D003609 | |
| Drug | ATFP | 7.28e-05 | 4 | 80 | 2 | CID000193783 | |
| Drug | 2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one | 8.42e-05 | 402 | 80 | 8 | ctd:C093973 | |
| Drug | 4-aminoazobenzene | 8.63e-05 | 66 | 80 | 4 | CID000006051 | |
| Drug | hydroxamates | 9.09e-05 | 25 | 80 | 3 | CID000033630 | |
| Drug | enzacamene | 9.24e-05 | 129 | 80 | 5 | ctd:C038939 | |
| Drug | chondroitin sulfate | 1.02e-04 | 413 | 80 | 8 | CID000024766 | |
| Drug | LMWH | COL3A1 COL4A6 COL24A1 COL7A1 FBLN2 COL17A1 HS6ST1 TLX2 COL1A1 COL1A2 | 1.08e-04 | 663 | 80 | 10 | CID000000772 |
| Drug | (2s,5s)-5-Carboxymethylproline | 1.19e-04 | 314 | 80 | 7 | CID000447989 | |
| Drug | Saralasin | 1.21e-04 | 5 | 80 | 2 | ctd:D012504 | |
| Drug | Flunarizine | 1.21e-04 | 5 | 80 | 2 | DB04841 | |
| Drug | L-3,4-dehydroproline | 1.28e-04 | 73 | 80 | 4 | CID000094284 | |
| Drug | rebamipide | 1.42e-04 | 75 | 80 | 4 | ctd:C052785 | |
| Drug | AC1L18QD | 1.47e-04 | 325 | 80 | 7 | CID000000213 | |
| Drug | N-acetyl-4-benzoquinoneimine | 1.57e-04 | 77 | 80 | 4 | ctd:C028473 | |
| Drug | BPAT-143 | 1.81e-04 | 6 | 80 | 2 | CID000146249 | |
| Drug | 3,4-dihydroquinazoline | 1.81e-04 | 6 | 80 | 2 | CID000583065 | |
| Drug | o-xylylene dibromide | 1.81e-04 | 6 | 80 | 2 | CID000066665 | |
| Drug | polyhexamethyleneguanidine | 2.06e-04 | 153 | 80 | 5 | ctd:C060540 | |
| Drug | isodesmosine | 2.11e-04 | 33 | 80 | 3 | CID000013811 | |
| Drug | paricalcitol | 2.52e-04 | 87 | 80 | 4 | ctd:C084656 | |
| Drug | AC1NDX9W | 2.52e-04 | 35 | 80 | 3 | CID004633087 | |
| Drug | ammonium perchlorate | 2.53e-04 | 7 | 80 | 2 | ctd:C053506 | |
| Drug | LY215840 | 2.53e-04 | 7 | 80 | 2 | CID000132049 | |
| Drug | neo-gambogic acid | 2.53e-04 | 7 | 80 | 2 | ctd:C045863 | |
| Drug | Oi-1 | 2.53e-04 | 7 | 80 | 2 | CID000448053 | |
| Drug | (1S,2R)-1-amino-1-thiazolidin-2-yl-propan-2-ol | 2.87e-04 | 90 | 80 | 4 | CID015942693 | |
| Drug | AC1L3XKP | 2.98e-04 | 37 | 80 | 3 | CID000123931 | |
| Drug | ELAN | 2.98e-04 | 37 | 80 | 3 | CID000009469 | |
| Drug | Okadaic Acid | 3.30e-04 | 263 | 80 | 6 | ctd:D019319 | |
| Drug | pyrvinium pamoate; Up 200; 1.25uM; MCF7; HT_HG-U133A_EA | 3.35e-04 | 170 | 80 | 5 | 978_UP | |
| Drug | HHMD | 3.37e-04 | 8 | 80 | 2 | CID000171068 | |
| Drug | Silicates | 3.37e-04 | 8 | 80 | 2 | ctd:D017640 | |
| Drug | SCH-12679 | 3.37e-04 | 8 | 80 | 2 | CID000005024 | |
| Drug | Neurotensin | 3.37e-04 | 8 | 80 | 2 | ctd:D009496 | |
| Disease | Ehlers-Danlos Syndrome | 1.98e-07 | 5 | 81 | 3 | C0013720 | |
| Disease | Familial thoracic aortic aneurysm and aortic dissection | 3.56e-07 | 53 | 81 | 5 | C4707243 | |
| Disease | Ehlers-Danlos syndrome | 1.10e-06 | 8 | 81 | 3 | cv:C0013720 | |
| Disease | Ehlers-Danlos syndrome (is_implicated_in) | 1.65e-06 | 9 | 81 | 3 | DOID:13359 (is_implicated_in) | |
| Disease | osteogenesis imperfecta type 3 (is_implicated_in) | 7.44e-06 | 2 | 81 | 2 | DOID:0110339 (is_implicated_in) | |
| Disease | EHLERS-DANLOS SYNDROME, ARTHROCHALASIA TYPE | 7.44e-06 | 2 | 81 | 2 | C0268345 | |
| Disease | EHLERS-DANLOS SYNDROME, ARTHROCHALASIA TYPE, 1 | 7.44e-06 | 2 | 81 | 2 | C4551623 | |
| Disease | osteogenesis imperfecta type 4 (is_implicated_in) | 7.44e-06 | 2 | 81 | 2 | DOID:0110340 (is_implicated_in) | |
| Disease | osteogenesis imperfecta type 2 (is_implicated_in) | 7.44e-06 | 2 | 81 | 2 | DOID:0110341 (is_implicated_in) | |
| Disease | OSTEOGENESIS IMPERFECTA, TYPE IV | 7.44e-06 | 2 | 81 | 2 | 166220 | |
| Disease | Osteogenesis imperfecta with normal sclerae, dominant form | 7.44e-06 | 2 | 81 | 2 | cv:C0268363 | |
| Disease | Osteogenesis imperfecta type III | 7.44e-06 | 2 | 81 | 2 | cv:C0268362 | |
| Disease | OSTEOGENESIS IMPERFECTA, TYPE II | 7.44e-06 | 2 | 81 | 2 | 166210 | |
| Disease | Osteogenesis imperfecta, perinatal lethal | 7.44e-06 | 2 | 81 | 2 | cv:C0268358 | |
| Disease | OSTEOGENESIS IMPERFECTA, TYPE III | 7.44e-06 | 2 | 81 | 2 | 259420 | |
| Disease | EHLERS-DANLOS SYNDROME, CLASSIC TYPE, 1 | 2.23e-05 | 3 | 81 | 2 | C4552122 | |
| Disease | Ehlers-Danlos Syndrome, Autosomal Dominant, Type Unspecified | 2.23e-05 | 3 | 81 | 2 | C0220679 | |
| Disease | osteogenesis imperfecta (is_implicated_in) | 2.23e-05 | 3 | 81 | 2 | DOID:12347 (is_implicated_in) | |
| Disease | osteogenesis imperfecta type 3 (implicated_via_orthology) | 2.23e-05 | 3 | 81 | 2 | DOID:0110339 (implicated_via_orthology) | |
| Disease | OSTEOPOROSIS | 4.45e-05 | 4 | 81 | 2 | 166710 | |
| Disease | Osteogenesis imperfecta, dominant perinatal lethal | 7.40e-05 | 5 | 81 | 2 | C0268358 | |
| Disease | osteogenesis imperfecta (implicated_via_orthology) | 7.40e-05 | 5 | 81 | 2 | DOID:12347 (implicated_via_orthology) | |
| Disease | Lobstein Disease | 7.40e-05 | 5 | 81 | 2 | C0023931 | |
| Disease | renal carcinoma (biomarker_via_orthology) | 7.40e-05 | 5 | 81 | 2 | DOID:4451 (biomarker_via_orthology) | |
| Disease | Osteoporosis | 1.11e-04 | 6 | 81 | 2 | cv:C0029456 | |
| Disease | Ehlers-Danlos syndrome (implicated_via_orthology) | 1.11e-04 | 6 | 81 | 2 | DOID:13359 (implicated_via_orthology) | |
| Disease | Autoimmune Lymphoproliferative Syndrome Type 2B | 1.55e-04 | 7 | 81 | 2 | C1846545 | |
| Disease | Bleeding tendency | 1.55e-04 | 7 | 81 | 2 | C1458140 | |
| Disease | Liver Cirrhosis | 1.90e-04 | 103 | 81 | 4 | C0023890 | |
| Disease | Fibrosis, Liver | 2.04e-04 | 105 | 81 | 4 | C0239946 | |
| Disease | Early Pregnancy Loss | 2.36e-04 | 109 | 81 | 4 | C3830362 | |
| Disease | Miscarriage | 2.36e-04 | 109 | 81 | 4 | C4552766 | |
| Disease | Spontaneous abortion | 2.36e-04 | 109 | 81 | 4 | C0000786 | |
| Disease | Abortion, Tubal | 2.36e-04 | 109 | 81 | 4 | C0000822 | |
| Disease | bladder neck obstruction (biomarker_via_orthology) | 2.65e-04 | 9 | 81 | 2 | DOID:13948 (biomarker_via_orthology) | |
| Disease | Osteogenesis imperfecta type IV (disorder) | 3.30e-04 | 10 | 81 | 2 | C0268363 | |
| Disease | Fibrosis | 3.56e-04 | 50 | 81 | 3 | C0016059 | |
| Disease | Cirrhosis | 3.56e-04 | 50 | 81 | 3 | C1623038 | |
| Disease | Nephrosclerosis | 4.03e-04 | 11 | 81 | 2 | C0027719 | |
| Disease | Aortic Valve Insufficiency | 4.03e-04 | 11 | 81 | 2 | C0003504 | |
| Disease | Osteogenesis imperfecta type III (disorder) | 4.03e-04 | 11 | 81 | 2 | C0268362 | |
| Disease | breast carcinoma | SHANK1 COL5A2 ARID1B GLI2 PLCL2 NKX2-6 KLHDC7A MN1 COL1A1 COL1A2 | 4.71e-04 | 1019 | 81 | 10 | EFO_0000305 |
| Disease | rheumatic heart disease (biomarker_via_orthology) | 4.83e-04 | 12 | 81 | 2 | DOID:0050827 (biomarker_via_orthology) | |
| Disease | Osteogenesis Imperfecta | 5.69e-04 | 13 | 81 | 2 | C0029434 | |
| Disease | pulse pressure measurement, social deprivation | 6.63e-04 | 14 | 81 | 2 | EFO_0005763, EFO_0009696 | |
| Disease | Schizophreniform Disorders | 6.63e-04 | 14 | 81 | 2 | C0036358 | |
| Disease | Psychosis, Brief Reactive | 6.63e-04 | 14 | 81 | 2 | C0033958 | |
| Disease | Malignant neoplasm of breast | NCOA6 COL7A1 ARID1B TRMT2A GRIN2D KLHDC7A REPS2 ZNHIT2 PRRC2A CIC | 7.07e-04 | 1074 | 81 | 10 | C0006142 |
| Disease | photoreceptor cell layer thickness measurement | 7.49e-04 | 148 | 81 | 4 | EFO_0803370 | |
| Disease | Hemoglobin F Disease | 7.64e-04 | 15 | 81 | 2 | C0019025 | |
| Disease | Blood Coagulation Disorders | 8.71e-04 | 16 | 81 | 2 | C0005779 | |
| Disease | Tetralogy of Fallot | 8.71e-04 | 16 | 81 | 2 | C0039685 | |
| Disease | Oral Submucous Fibrosis | 1.11e-03 | 18 | 81 | 2 | C0029172 | |
| Disease | Hydrops Fetalis | 1.23e-03 | 19 | 81 | 2 | C0020305 | |
| Disease | Anophthalmia-microphthalmia syndrome | 1.51e-03 | 21 | 81 | 2 | cv:C5680330 | |
| Disease | Osteogenesis imperfecta | 1.51e-03 | 21 | 81 | 2 | cv:C0029434 | |
| Disease | Attention Deficit Disorder | 1.66e-03 | 22 | 81 | 2 | C0041671 | |
| Disease | Minimal Brain Dysfunction | 1.66e-03 | 22 | 81 | 2 | C1321905 | |
| Disease | Attention deficit hyperactivity disorder | 1.98e-03 | 24 | 81 | 2 | C1263846 | |
| Disease | Left Ventricular Hypertrophy | 2.14e-03 | 25 | 81 | 2 | C0149721 | |
| Disease | Heart valve disease | 2.32e-03 | 26 | 81 | 2 | C0018824 | |
| Disease | Psychotic Disorders | 2.74e-03 | 101 | 81 | 3 | C0033975 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| GEGGTPAPASLPGGS | 176 | Q96PM9 | |
| APGALAGGPTQAAPG | 111 | Q9BXH1 | |
| GSSSFGLNLQGPPGP | 941 | Q9UMD9 | |
| PGALGIPSGPSEGGS | 971 | Q9UMD9 | |
| GLKGSPGSPGVAGLP | 876 | Q14031 | |
| PGLPGSSGHQGAIGP | 1141 | Q14031 | |
| TPGSGSGSGLQAPGP | 336 | P19419 | |
| LGNLLGPAGPGAGGS | 611 | P46379 | |
| PGGASGPGLDSHLQP | 66 | Q9BZE3 | |
| SQVGGGPAGPALPNG | 11 | Q14576 | |
| NSLGGAGGGAPQPGP | 221 | Q8NFD5 | |
| GLPGAGLPSTGLPGS | 666 | Q9NTZ6 | |
| PNNLSGPSGFGGGPQ | 776 | Q9NTZ6 | |
| PQPGLNAASPLGGGT | 91 | A6NCS4 | |
| AVGGSAGAPPLGPSQ | 26 | P21918 | |
| SAGPGPGLSLGPGPS | 41 | Q96EP9 | |
| LNGPGVGGPPSAAAA | 56 | A8MTJ6 | |
| AAGPGRSGPGPGLGS | 96 | Q96JE9 | |
| GGPPAALGGGSQPLS | 226 | P98095 | |
| TGPNGSAHSQPLPGG | 76 | Q9HCR9 | |
| AAAGNQPGGNPSPGG | 836 | P16499 | |
| PGSGSGSGPGLAPAR | 771 | Q8IX07 | |
| LPPGGGAARAGPGLS | 1286 | Q7Z7M0 | |
| FSGSGGGGPAGLLPN | 771 | P10070 | |
| SPPGGELSPGAGRAG | 281 | Q99958 | |
| AGPGLSLGAPGGRAP | 36 | O60243 | |
| FRPPPGSGLGNLGAG | 806 | Q9Y3Q4 | |
| NSLAPPGKAGGGSGP | 306 | Q9BRQ0 | |
| PPQAPAGGLGGASGA | 6 | Q8IZL2 | |
| PGTASAGPSLPGGAL | 1896 | Q14686 | |
| SGLQGSPAGFPPGGF | 1091 | O14976 | |
| PPGNPGANGLTGAKG | 296 | P08123 | |
| APGSAPGNPGLNGRS | 1441 | Q14674 | |
| APAGGSGALPGAVGP | 106 | O15499 | |
| LQPVYPGPGAGSSGG | 166 | Q13351 | |
| DPSNLGGQPLGGPGS | 2286 | O43497 | |
| AGVLGGPATPASGPG | 401 | Q9NPF5 | |
| GASGGGGPINPASLP | 31 | Q96IK1 | |
| PGPPASGAGGAANGT | 356 | Q9BZC7 | |
| DAGSPGPQGLAGSPG | 871 | P05997 | |
| SAGSPGRAGLPGSPG | 326 | Q9UEW3 | |
| GRAGLPGSPGSPGAT | 331 | Q9UEW3 | |
| EPLPGGSPGGSGSAL | 1011 | O75064 | |
| PPPGSLGTGAASGGQ | 321 | Q5VTJ3 | |
| GPQGLPGLAGTAGEP | 996 | P02461 | |
| KPGAAGPSGPNGAAG | 1786 | Q02388 | |
| AVPGAGPGSLTPGGA | 271 | Q9H0L4 | |
| PGTGGHGPLSLNSPD | 641 | O95180 | |
| QGLGGGPPGLAPAAV | 216 | O75364 | |
| SSGNGGGYGGPAQPP | 11 | P15407 | |
| PSGSSGPGQAGQPGA | 196 | Q96G25 | |
| PSPGLQFGGSLGGLG | 696 | Q10571 | |
| GAVGLLPPGAAAPSG | 956 | Q5ST30 | |
| LGGAGGGSSPSKSPP | 711 | Q5T011 | |
| GSHGQTPSPGALPLG | 431 | P17600 | |
| GAGAATGPGPQPGLY | 46 | Q8IZ69 | |
| QGSPGGGPGPRSLSG | 76 | Q8IYL2 | |
| PGAPGGPQLAGSSAG | 131 | O75157 | |
| PGAAPGQPGAGSRGS | 191 | O76081 | |
| RGGAAGGALPTSPGP | 6 | Q9UPR0 | |
| GPALGGLSCSPNLPG | 311 | Q5U5Q3 | |
| LQPGGQSGFLPSGAP | 1961 | P48634 | |
| GAPGPGGALGSQAPS | 6 | O15357 | |
| EPTSGPPGNNGGSLL | 16 | Q9UBF8 | |
| LSPLGAGPGSGGGPA | 221 | Q9Y2V3 | |
| PPHPGISGGLGGALS | 2056 | Q9Y566 | |
| QAPGSGAPAPAGISG | 596 | P0C7V6 | |
| GLGGPLPGSSPARGA | 16 | Q9H6R3 | |
| AGAGSGPNGPVPLGI | 796 | Q96RK0 | |
| GAPGSQGAPGLQGMP | 716 | P02452 | |
| PNGLGPSGASGPALG | 36 | Q86TL0 | |
| PSGASGPALGSPGAG | 41 | Q86TL0 | |
| PSGQTGDPGLQGPSG | 751 | Q17RW2 | |
| GPAAALGPRGPLGSG | 251 | P98169 | |
| SRGPLPGGFSGGNPL | 316 | Q9Y330 | |
| AAGGGCGSGPPPLLL | 16 | Q8NFH8 | |
| PGQSAAPTLAGGGGG | 141 | Q8TEJ3 | |
| STAPLGPGAAGPGTG | 161 | O95271 | |
| GLPGGPPSTVASGAG | 11 | Q86TL2 | |
| PGEAGLSSGPAPGGL | 81 | Q9UHR6 | |
| LVAPPGGPNGDSSGG | 966 | Q9NPG3 | |
| NGLPNGGGAGDSLPG | 71 | Q13425 | |
| LAPLPGSSGVGPGGV | 66 | O43763 | |
| GAAGPAPGTGSGPLR | 76 | Q5T447 | |
| NVSLGATGGPPAGPG | 156 | P17275 | |
| PESQPLLGPGAGGAG | 1066 | O15399 |